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1I.  Review of Resistance in the Environment 
 Introduction 
Antibiotics have long been considered the “magic bullet” that would end 
infectious disease.  Although they have improved the health of countless numbers 
of humans and animals, many antibiotics have also been losing their effectiveness 
since the beginning of the antibiotic era.  Bacteria have adapted defenses against 
these antibiotics and continue to develop new resistances, even as we develop 
new antibiotics.  In recent years, much attention has been given to the increase in 
antibiotic resistance.  As more microbial species and strains become resistant, 
many diseases have become difficult to treat, a phenomenon frequently ascribed 
to both indiscriminate and inappropriate use of antibiotics in human medicine.  
However, the use of antibiotics and antimicrobials in raising food animals has 
also contributed significantly to the pool of antibiotic resistant organisms globally 
and antibiotic resistant bacteria are now found in large numbers in virtually every 
ecosystem on earth.   
There is no doubt that the use of antibiotics provides selective pressure 
that results in antibiotic resistant bacteria and resistance genes.  While some 
resistant bacteria are found naturally in the environment, pathogens and non-
pathogens are released into the environment in several ways, contributing to a 
web of resistance that includes humans, animals, and the environment, essentially 
the biosphere.  Reviewed here are the history and scope of both antibiotics and 
resistance, the mechanisms of resistance, and evidence for the spread of antibiotic 
resistant organisms and resistance genes through humans, animals, and the 
environment. 
2History of antibiotic development 
 
In order to comprehend the problem of antibiotic resistance as it exists 
today, it is useful to understand the history and development of both antibiotics 
and antibiotic resistance.  Antimicrobial drugs have generally been classified into 
two categories, one includes the synthetic drugs, such as the sulfonamides and the 
quinolones, and the second, antibiotics, synthesized by microorganisms. In recent 
years, increasing numbers of semi-synthetic drugs have been developed which are 
chemical derivatives of antibiotics, thereby blurring the distinction between 
synthetic and natural antibiotics.    
Interest in antimicrobial chemotherapy was kindled as soon as 
microorganisms were understood to be agents of infectious disease.  In earlier 
times, plant products were sometimes used successfully in the treatment of 
disease, but neither doctors nor patients knew the basis for the action of these 
therapeutic agents.  Many early medicines were used to cure protozoan diseases, 
rather than bacterial diseases.  As early as 1619, it was known that malaria could 
be treated with the extract of cinchona bark (quinine) and that amoebic dysentery 
could be treated with ipecacuanha root (emetine) (91, 100).  Only a few 
antibacterials, such as mercury, which was used to treat syphilis, were in use 
when the era of true chemotherapy began.   
It was in the early 1900's when Paul Ehrlich first hypothesized that dyes 
could be used as antimicrobial drugs, based on their differential affinities for 
3various tissues.  In 1904, Ehrlich and Shiga discovered that a red dye called 
trypanrot  was effective against trypanosomes (183).  It was around this time that 
arsenicals drew Ehrlich's interest.  Ehrlich, along with Sahachiro Hata in 1909, 
found that arsphenamine (named Salvarsan) was active against spirochetes and, 
therefore, was an effective cure for syphilis (100).   
The first truly effective class of antimicrobial drugs were the 
sulfonamides, discovered by Gerhard Domagk (73).  In 1932, two scientists at the 
Bayer company, Mietzsch and Klarer, synthesized Prontosil red, a red dye bound 
to a sulfonamide group.  Domagk (73) showed, in 1935, that infections in mice 
caused by hemolytic streptococci were cured by Prontosil red (91, 100).  
Unfortunately for Bayer, Prontosil red was shown to have no antibacterial activity 
in vitro. This lack of activity was explained by Tréfouël et al. (259) when they 
showed that Prontosil red is split in vivo into its component dye and 
sulfanilamide, the active antibacterial agent and a previously described molecule 
that was already in the public domain.  From that point, sulfanilamide was 
manufactured by a number of companies and work was begun to modify the 
molecule to enhance performance, leading to decreased side effects and a broader 
spectrum of action.   
Although penicillin was the first natural antibiotic to be discovered, the 
idea of using microorganisms therapeutically was not new.  Fungi had been used 
in poultices for many years, and by 1899, a product called pyocyanase, which was 
an extract from Pseudomonas aeruginosa, was used in the treatment of wounds 
(91).  Penicillin was first isolated from Penicillium notatum in 1928 by Alexander 
4Fleming (81), but he was unable to isolate and purify enough drug to be of any 
use.  By 1941, Ernst Chain, Howard Florey, and Norman Heatley had shown the 
therapeutic value of penicillin (49), but they were also unable to produce enough 
penicillin for commercial use.  Collaboration with Andrew Moyer and Robert 
Coghill (191) at the USDA's Northern Regional Research Laboratory in Illinois 
led to much higher production yields of penicillin by 1943.  After a worldwide 
search for Penicillium strains that could produce more penicillin, Raper and 
Fennel (219) found a strain of Penicillium chrysogenum on a moldy cantaloupe at 
a local market that was capable of even higher yields  of penicillin (70). 
A series of different antibiotics were quickly discovered after penicillin 
came into use.  In 1940, Selman Waksman began searching for antibiotic 
compounds produced by soil microorganisms (100).  In 1943, one of Waksman's 
students discovered streptomycin (234), leading to a flood of researchers combing 
the world for new drugs.  It was in this same period that Rene Dubos (117) 
discovered gramicidin, the first antibiotic active against gram-positive bacteria.  
Chlortetracycline, chloramphenicol, and others were discovered shortly thereafter 
(91).  Many discoveries were of drugs that were too toxic for human use, or that 
had already been discovered.  Nevertheless, this work did lead to many new drugs 
and within only 10 years, drugs comprising the major classes of antibiotics were 
found (100).  In addition to soil, many of these drugs were discovered by isolating 
the producing microorganisms from interesting and unusual sources.  For 
example, some antibiotic-producing bacteria were isolated from a wound 
5infection and others from sewage, a chicken's throat, and a wet patch of wall in 
Paris (91).   
In 1962, one of the later discoveries was a synthetic drug, nalidixic acid, 
the first of the quinolones to be described, and although not therapeutically 
important by itself, modification of nalidixic acid led to the production of the 
highly effective fluoroquinolones.  Members of this class, such as ciprofloxacin, 
norfloxacin, enrofloxacin, and ofloxacin, have become very important in the 
treatment of diseases in both humans and animals (183).  Since the 1960's, there 
have been few discoveries of new antibiotic drugs.  The drugs developed since 
have mostly been chemical modifications of existing drugs.  These modifications 
have been very useful in treating infectious diseases, leading to enhanced killing 
of pathogens, increased spectrum of action, reduced toxicity, and reduced side-
effects.  Unfortunately, since the 1970's, only one new class of antibiotics has 
been introduced (155) and a recent trend in antibiotic therapy has been to employ 
combinations of drugs with different mechanisms of action, in order to increase 
their effectiveness and to overcome the problem of drug resistance.   
 
History and scope of resistance 
 
There is evidence that although resistant microorganisms existed in nature 
before the use of antibiotics, such microorganisms were mostly absent from 
human flora (119).  However, in the intervening years, antibiotic resistant 
microorganisms have become frighteningly common.  Almost as soon as 
6antibiotics were discovered, researchers began to find microorganisms resistant to 
the new drugs.  Even by 1909, when Ehrlich first began to study dyes and 
arsenicals, he found drug resistant trypanosomes (100).  Resistant strains of 
Staphylococcus aureus in hospitals grew from less than 1% incidence, when 
penicillin first came into use, to 14% in 1946, to 38% in 1947, to more than 90% 
today (100).  Worldwide, ampicillin and penicillin resistance can be found 
together in more than 80% of S. aureus strains (199).  After World War II, 
sulfonamides were widely used to treat Shigella infections in Japan, but by 1952, 
only 20% of isolates were susceptible.  As the Japanese began to switch to 
tetracycline, chloramphenicol, and streptomycin, Shigella strains that were 
multiply-resistant quickly began to appear (80). Within 30 years of their 
discovery, sulfonamides ceased to be an effective treatment for meningococcal 
disease (199).  In the years since, reports of resistance have grown increasingly 
common, and pathogens that are resistant to almost all antibiotics have been 
found.  It has become painfully obvious that antibiotic resistance is reaching a 
crisis stage and some clinicians have even forecasted that we are facing a return to 
the devastating diseases of the pre-antibiotic era (25, 119, 155).   
In general, as stated above, resistance has been found in many organisms, 
but some pathogens are of particular recent concern.  These pathogenic organisms 
are becoming increasingly more common, especially with the greater frequency of 
travel worldwide and increase in the population of the elderly, both in the United 
States and in many of the developed countries worldwide.  Some specific 
7examples of microbial species that have developed  significant resistance are cited 
as follows. 
Enterococcus spp.: 
The enterococci are a group of gram-positive cocci that are part of the 
normal resident flora of both humans and some animals (179, 261).  They are 
generally not considered virulent; however, their intrinsic resistance to many 
antibiotics (including cephalosporins, penicillin, and aminoglycosides) has made 
them important opportunistic pathogens and one of the most common causes of 
nosocomial infections.  In fact, 12% of  nosocomial infections in the United States 
are caused by enterococci, with Enterococcus faecium and Enterococcus faecalis 
the most important and common species (261, 269).  Although the enterococci are 
opportunistic pathogens, they are a frequent cause of urinary tract infections, 
bacteremia, and endocarditis, all of which can be difficult to treat due to 
resistance.  Mortality rates in enterococcal bacteremia can reach 70% (179).   
The traditional method of treatment has been a combination of an 
aminoglycoside and ampicillin or a glycopeptide.  By the 1970's, only ampicillin 
and vancomycin (a glycopeptide) were effective treatment options in most cases 
(83).  As of 2000, high level resistance to ampicillin and aminoglycosides was 
common, leaving vancomycin as the treatment of last resort (128).  In one study 
in New York City, Frieden et al. (83) found that 98% of vancomycin resistant 
enterococci (VRE) infections were acquired nosocomially and 19% of these were 
resistant to all antibiotics.  Although vancomycin has been used in humans for 
more than 40 years, VRE were not generally considered a clinical problem until 
8recently.  The first report of VRE in the lab was in 1969, but the first clinical 
cases were not seen until 1986 in England, and in 1988 in New York City (28, 
83).  Since then, the frequency of VRE infections has vastly increased, becoming 
a major health problem.  Enterococcal glycopeptide resistance in intensive care 
units in the United States grew from 0.4% in 1989 to 16% in 1997.  Furthermore, 
from 1989 to 1993, there was a 20-fold increase in nosocomial VRE  infections 
(48, 141).  In 1998, it was reported that approximately 20% to 40% of 
enterococcal nosocomial infections were vancomycin resistant (140).  So far, in 
the United States, clinical VRE isolates have been mostly confined to the hospital 
setting, with no reports of community carriage (169).  In Europe, there have been 
many reports of community-acquired infections, with community carriage rates 
ranging from 2% in England to 28% in Belgium (28, 169).  This difference in 
source has so far been unexplained, but some attribute it to the use of 
glycopeptide antibiotics in food animals in Europe.  A recently approved drug for 
the treatment of VRE is the streptogramin combination of 
quinupristin/dalfopristin.  Although only approved since 1999, there have already 
been reports of sporadic resistance in human isolates and resistance is quite 
common on retail foods and in food animals (242).   
Staphylococcus spp.: 
The staphylococci are another group of gram positive cocci that are often 
associated with infections, especially nosocomial infections, and antibiotic 
resistance.  In the clinical setting, they are divided into two groups: the coagulase- 
positive and the coagulase-negative staphylococci.  The most important species of 
9the coagulase-negative staphylococci is Staphylococcus epidermidis. These are 
the most common of the skin microbiota and are generally believed to be simply 
opportunistic pathogens.   
In contrast, the most important pathogen of the staphylococci is 
Staphylococcus aureus. S. aureus is coagulase-positive and is commonly found 
on the skin and in the nasal passages of carriers.  S. aureus infections are often 
nosocomial or opportunistic and can cause pimples, furuncles, impetigo in 
newborns, pneumonia, endocarditis, and septicemia (149).  There are several 
virulence factors that determine the pathogenicity of S. aureus. These include 
several toxins that can cause such effects as toxic shock syndrome and food 
poisoning.   
Antibiotic resistance in staphylococci is very common and was observed 
very early in the antibiotic era.  When general use of penicillin began, nearly all 
staphylococcal isolates were susceptible when tested in the laboratory, but 
resistance to penicillin and other N-lactam antibiotics, including ampicillin, in 
hospitals began to appear almost immediately, so that by 1948, 59% of S. aureus 
strains isolated from patients in hospitals were resistant.  By 1950, the majority of 
the strains from most hospitals around the world were penicillin resistant (91).  
Although the first penicillin resistant S. aureus strains were generally only found  
in hospitals, the pathogen moved rapidly into the community.  Today, more than 
90% of S. aureus and between 50% and 70% of coagulase-negative staphylococci 
are resistant (100, 199).  In fact, in one recent community prevalence study of 
healthy young volunteers in Portugal, Sá-Leão et al. (231) found that 94% of 
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S. aureus strains were resistant either to penicillin alone, or to penicillin and 
erythromycin. 
Resistance to other antibiotics similarly appeared shortly after their 
introduction.  By 1953, staphylococcal resistance to streptomycin, tetracycline, 
chloramphenicol, and novobiocin had been reported.  Through the 1950s, a 
pandemic was caused by a particularly virulent and penicillin resistant strain of 
S. aureus called phage type 80/81.  After the discovery of penicillinase-resistant 
drugs such as methicillin, the pandemic was brought under control (224).  
Although these resistances were reported in separate strains and sometimes 
together in single, highly epidemic strains, it was believed that such resistances 
were rare and of little significance (91).  Even resistance to newer drugs, such as 
the fluoroquinolones and quinupristin/dalfopristin, was reported (100, 250).  In 
the early 1960s, S. aureus strains resistant to supposedly penicillinase-resistant 
N-lactam drugs, such as methicillin, began to appear in hospitals (91).  Methicillin 
resistant S. aureus (MRSA) quickly spread around the world and are now a major 
nosocomial pathogen.  In 2000, 47% of S. aureus and 75% of coagulase-negative 
staphylococcal isolates from intensive care units in the U.S., and 48% of hospital 
isolates in Portugal were methicillin resistant (231, 250).  Until recently, MRSA 
was mainly a hospital problem; however, there have been reports of community-
acquired infection in several countries.  MRSA among children in day-care 
centers, sports teams, and other groups have been reported, including several 
deaths (231).  Although community prevalence appears to be low (1%-2%), there 
is increasing concern over the threat of MRSA, since many strains are resistant 
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not only to methicillin, but to all antibiotics except the glycopeptides, making 
them very difficult to treat (100).   
Currently, the only available drug for treatment of MRSA infections is 
vancomycin.  In 1997, in Japan, vancomycin resistant S. aureus (VRSA) was first 
isolated (168).  This discovery was quickly followed by VRSA isolates in the U.S. 
and other countries (250).  The discovery of VRSA prompted fears that 
vancomycin resistance had come from VRE, especially after it was reported that 
the vancomycin resistance gene vanA could be transferred from E. faecalis to 
S. aureus in vitro (195).  For several years, no connection to VRE could be found 
(250), but as of 2004, strains of VRSA containing the vanA gene have been 
isolated from patients in the U.S. (227, 274). 
There has been some disagreement over the designation VRSA, as many 
of the strains that have been isolated do not meet the NCCLS standards for 
resistance.  Therefore, the term, vancomycin intermediate S. aureus (VISA), has 
come into use.  It is important to note, however, that even if VISA strains may not 
meet the criteria for resistance in vitro, infected patients frequently fail to respond 
to vancomycin, effectively indicating bacterial resistance (227, 230).  Although 
VRSA isolates, to this point in time, have been treatable by other antibiotics, it is 
easy to see the danger inherent in such resistant organisms, especially if one 
considers the possibility of transfer of the resistance to other bacterial species. 
Streptococcus spp.: 
Streptococcal infections are a major cause of disease around the world.  
The three main pathogens of concern are Streptococcus pneumoniae,
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Streptococcus pyogenes, and Streptococcus agalactiae. S. pneumoniae, or
pneumococcus, is the leading cause of both meningitis and septicemia.  In 
addition, S. pneumoniae can cause pneumonia, sinusitis, otitis media, and other 
respiratory infections and is responsible for 40,000 deaths each year in the U.S. 
alone (127, 198).  In young children, the elderly, and immunosuppressed 
individuals, S. pneumoniae infections are particularly dangerous.  Pneumococcal 
infection is the main cause of the 5 million pneumonia deaths worldwide among 
children under age five (127). 
S. pyogenes also causes serious, sometimes fatal disease.  This species is 
the cause of scarlet fever, impetigo, otitis media, meningitis, puerperal fever, skin 
infections, and is the most common cause of bacterial pharyngitis.  More serious 
infections include streptococcal toxic shock syndrome and necrotizing fasciitis.  
S. pyogenes can also lead to post-infection complications, including rheumatic 
arthritis, rheumatic heart disease, and acute glomerulonephritis.  Furthermore, 
there may be an association between infection and Tourette's syndrome (60).    
S. agalactiae, also known as Group B streptococcus (GBS), was first 
recognized as an important cause of puerperal fever.  While it sometimes causes 
bacteremia, pneumonia, and tissue infections in adults (especially in those with 
diabetes or cancer), it is the leading cause of neonatal sepsis (18).  In the 1970s, 
the mortality rate of GBS among newborns was found to be 55% (72), prompting 
the medical community to seek an effective treatment.  The Centers for Disease 
Control and Prevention (CDC) has since issued guidelines directing that 
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intrapartum prophylaxis be given to mothers at high risk.  These measures have 
resulted in an attack rate of only 0.02% and a mortality rate of 5% (18, 72).   
By the time penicillin came into use, both S. pneumoniae and  S. pyogenes 
were commonly resistant to the sulfonamides.  Unlike in other organisms, 
penicillin resistance was very slow to develop and, at least until 1971, it was 
believed that neither organism was capable of developing resistance (91).  In 
1977, however, penicillin resistant strains of S. pneumoniae were isolated from 
fatal meningitis cases in South Africa (199).  Since then, resistance to penicillin 
has been on the rise throughout the world, reaching even to Iceland and New 
Guinea, with rates as high as 50% (168, 204).  In Europe, penicillin resistance 
rates of S. pneumoniae vary by country with Spain (40%) being the highest and 
the U.K. the lowest (4%).  Most countries have rates less than 10% (26).   
Resistance to other antibiotics has also developed in S. pneumoniae. Worldwide, 
there have been reports of streptococcal resistance to tetracycline, 
chloramphenicol, and erythromycin.  As in other organisms, antibiotic resistance 
generally follows the same pattern as antibiotic usage.  In Spain, chloramphenicol 
resistance occurred in 70% of hospital isolates in 1976, but decreased to 36% in 
1983 after the use of chloramphenicol in that country was reduced when serious 
side effects were revealed (26).   
Many strains have become multiply resistant and susceptible only to 
vancomycin (168).  In 1999, vancomycin tolerance was first reported in a clinical 
isolate of S. pneumoniae (198).  Since then, there have been reports of tolerant 
isolates in many countries, including Italy, Sweden, the U.S., and China (38, 110).  
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To date, there have been no reports of vancomycin resistance in S. pneumoniae,
however, vancomycin tolerance is a very important threat (38, 110, 204).  There 
are three notable concerns with vancomycin tolerance.  First, it is expected that 
tolerance will eventually result in full-blown resistance, as has occurred with 
VISA and VRSA (198).  Second, it is difficult to detect vancomycin tolerance in 
the laboratory using routine susceptibility tests, because such strains appear to be 
susceptible (38).  Third, and most critical, vancomycin tolerance generally leads 
to therapeutic failure, especially in cases of meningitis, which often have high 
mortality rates anyway (38).  One bright note is that there is a pneumococcal 
vaccine currently available that provides moderate protection from most strains 
causing infection.  Included among the strains against which the vaccine is 
effective are the majority of antibiotic resistant strains.  However, an improved 
vaccine is needed (127). 
 To date, S. pyogenes remains almost completely susceptible to penicillin, 
but resistance to other drugs, such as tetracycline and erythromycin, has been 
reported (40, 91).  Erythromycin resistance is increasing and has been associated 
with streptogramin resistance as well.  Erythromycin resistance rates in Italy 
reached as high as 31% by 1995 (40).  Penicillin tolerance has been reported in 
recent years, but it is relatively uncommon and treatment with amoxicillin and 
clavulanic acid or cephalosporins remains feasible (60).   
The treatment of choice for S. agalactiae infection remains penicillin, and 
resistance to this drug continues to be low.  However, resistances to several 
antibiotics have been reported.  Resistance to ampicillin, cefazolin, penicillin, and 
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vancomycin has been reported to be less than 2%, while clindamycin resistance is 
between 8% and 15%, and erythromycin resistance is between 16% and 19% (18, 
35, 212).    
Food and waterborne illnesses: 
The effect that food and waterborne diseases have had on world 
populations cannot be overstated.  Through history, millions of people have died, 
armies have faltered, and populations have been changed by diseases transmitted 
through food or water.  Today, gastrointestinal diseases continue to cause 
malnutrition and death in developing countries.  In the U.S. and other 
industrialized nations, while there are fewer deaths, many people are sickened 
each year by these diseases.  Some of the major food and waterborne bacterial 
pathogens are Campylobacter spp., Salmonella spp., Shigella spp., Vibrio spp., 
and Escherichia coli. These species cause disease around the world, and 
antibiotic resistance is an increasing problem in the treatment of the diseases 
they cause. 
The campylobacters are gram-negative, microaerophilic, rod-shaped 
bacteria that are frequently present in the gut of many animals, especially birds.  
They are also found in natural water sources and in many foods.  In fact, 
Campylobacter can be isolated from up to 98% of retail foods. The two most 
important pathogenic Campylobacter species are Campylobacter jejuni and 
Campylobacter coli (13).  Since the 1980s, campylobacters have been the most 
common cause of bacterial gastroenteritis in both the U.S. and the U.K. (13, 84).  
Although it is difficult to determine the actual number of cases, since many go 
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unreported, between 2.1 and 2.5 million cases of campylobacteriosis are believed 
to occur in the U.S. each year (13, 182).  Symptoms include diarrhea, cramping, 
and fever.  Complications such as bacteremia sometimes occur, and 
campylobacteriosis is also associated with post-infection diseases, i.e. Guillain-
Barre syndrome and Reiter syndrome (13).  Most outbreaks of campylobacteriosis 
are sporadic rather than epidemic, and many times the source goes 
unrecognized (84).   
Fortunately, Campylobacter infections are usually self limiting and 
antibiotic treatment is not always required.  However, in serious cases and 
especially in cases of Campylobacter bacteremia, treatment is advised, usually 
administration of erythromycin or fluoroquinolones.  Antibiotic resistance in 
campylobacters has increased drastically in recent years.  Fluoroquinolone 
resistance was first reported in the late 1980s, but since 1990, the incidence of 
resistance has increased.  For example, in the Netherlands, resistance went from 
11% in 1990, to 30% in 1991 (218).  In a study of U.S. troops in Thailand in 
1994, most isolates were resistant to ciprofloxacin (a fluoroquinolone) and 33% 
were resistant to azithromycin (an erythromycin derivative) (13). 
Salmonella spp. are gram-negative rods that inhabit the intestines of 
mammals, birds, and reptiles.  They are capable of surviving for long periods in 
water, soil, and food (17).  The two major diseases associated with Salmonella 
spp. are typhoid fever and salmonellosis.  Typhoid fever, caused by S. typhi, has 
characteristic features, namely, after an incubation period of two weeks, a high 
fever occurs, followed by headache and diarrhea.  Rather than multiplying in the 
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intestinal epithelium, S. typhi invades the phagocytes and spreads throughout the 
body.  The disease can lead to perforation of the intestinal wall, peritonitis, and 
septicemia and if any of these occurs, there is a high mortality rate (78).  
Although typhoid fever has decreased significantly in incidence in the developed 
world, 16.6 million cases occur annually worldwide, in developing countries 
predominantly, as well as 600,000 deaths (241).  In some parts of Asia, 30%-40% 
of hospital blood cultures are S. typhi (168).  Cases do occur in the U.S., but most 
of these are acquired during international travel. 
Salmonellosis caused by Salmonella species other than S. typhi, is usually 
a less severe illness.  It is often self-limiting and symptoms include diarrhea, 
fever, and abdominal cramps.  The most common sources of Salmonella 
infections are undercooked poultry or eggs and most cases go unreported.  It is 
estimated that in the U.S., there are 1.4 million cases of salmonellosis each year 
(17).  Due to the nature of the disease, antibiotics are usually not necessary for 
treatment; however, salmonellae can invade the bloodstream or other sites in the 
body and cause serious illness, requiring antibiotic treatment.  Ampicillin and 
chloramphenicol have historically been the main treatments for Salmonella 
infections (241).  Since 1988, though, ciprofloxacin has been the most prescribed 
drug for these infections (17).   
Multiple drug resistance in non-typhoidal Salmonella infections was 
common by the end of the 1960s and has increased drastically since then.  There 
have been several outbreaks of multiply resistant S. typhimurium associated with 
cattle and poultry (254).  In 1988 in England, a multiply resistant S. typhimurium 
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strain, DT104, was first isolated.  During the following decade, 90% of human 
DT104 isolates were found to be multiply resistant, i.e. ampicillin, 
chloramphenicol, streptomycin, sulfonamides, and tetracycline resistant.  This 
strain has since spread through Europe, the U.S. and many other parts of the 
world.  From 1997 to the present, resistance to trimethoprim and fluoroquinolones 
has appeared in DT104 isolates (140, 254).  Since 1986, there has been an 
increasing number of reports of multiply resistant S. typhi throughout the world.  
In Mexico, chloramphenicol resistance first appeared, followed by resistance to 
ampicillin, streptomycin, sulfonamides, and tetracycline.  Fluoroquinolone 
resistance has also been reported in S. typhi in developed countries (239).  
Ominously, many DT104 isolates resistant to ampicillin, chloramphenicol, 
streptomycin, sulfonamides and tetracycline are now exhibiting decreased 
susceptibility to fluoroquinolones (17). 
Shigella spp. are gram-negative rods that are very similar to species of the 
genus Escherichia. Four species of  Shigella, S. flexneri, S. sonnei, 
S. dysenteriae, and S. boydii, are pathogenic.  In the U.S., most shigellosis is 
caused by S. sonnei, but around the world, S. flexneri is the most common.  
Shigellae are capable of surviving the acidity of the stomach, and consequently, 
the infectious dose is low (129).   Invasion and tissue destruction in the intestinal 
epithelial layer leads to watery diarrhea, then bloody, mucoid diarrhea, as well as 
cramps and fever.  Usually, shigellosis is limited to gastrointestinal illness, but it 
can progress to bacteremia.  S. dysenteriae is often the culprit in serious cases and 
can have a mortality rate of 20% (23).  Throughout the world, 165 million cases 
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of shigellosis occur each year, almost all of which are in developing countries.  
However, 20-30 thousand cases occur in the U.S. annually.  Around the world, 
shigellosis is the cause of 1.1 million deaths and 69% of the cases are in children 
under age five (129).  Transmission is by the oral-fecal route and in developing 
countries is attributed to poor sanitation and lack of clean water.    
Antibiotics are useful in treatment of shigellosis since they reduce the 
length of time of the symptoms, as well as bacterial shedding, but antibiotic 
treatment is necessary in cases of bacteremia and severe diarrhea.  Early antibiotic 
resistance was detected in Japan, where dysentery caused by Shigella infection 
was a large problem.  By 1950, 80%-90% of Shigella isolates were resistant to 
sulfonamides, and by 1965, resistance to tetracycline, chloramphenicol, and 
streptomycin had been reported (183).   Since then, resistance continues to 
increase.  In Israel, the incidence of resistance to ampicillin is currently 85% and 
to trimethoprim-sulfamethoxazole, 94%, with resistance to tetracycline increasing 
from 23% in 1992 to 87% by 2000 (23).  Ciprofloxacin resistance has also been 
reported (23).   
Escherichia coli is a very common gram-negative rod normally found in 
the intestinal tract of mammals.  Not all strains are pathogenic, but those that are 
can cause sepsis, urinary-tract infections, meningitis, and gastroenteritis.  Most 
gastroenteritis caused by E. coli is self-limiting and requires no antibiotic 
treatment.  However, other diseases caused by E. coli, cited above, and E. coli 
enterohemorrhagic gastroenteritis are serious and do require antibiotic treatment.   
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As in the case of the microorganisms discussed above, antibiotic 
resistance is on the rise in E. coli. O'Brien et al. (199) reported an incidence for 
sulfonamide resistance of between 21% and 85%, ampicillin resistance between 
17% and 72%, tetracycline resistance between 24% and 60%, and trimethoprim 
resistance between 1% and 4%.  Resistance to fluoroquinolones was rare for 
many years, but since the early 1990s, this to, has been on the rise.  In one study 
in Spain, the incidence of resistance was shown to have reached 22% and more 
than a third of those isolates were resistant to three or more other antibiotics (90).  
In Taiwan, 11.3% of isolates are reported to be fluoroquinolone resistant and 
21.7% with reduced susceptibility.  Not surprisingly, it is believed that reduced 
susceptibility will lead to increased incidence in resistance (171).   
Other pathogens: 
There are many other antibiotic resistant microbial pathogens that have 
emerged in recent years.  Neisseria gonorrhoea, the causative agent of gonorrhea, 
is highly resistant to antibiotics in many countries of the world.  In Southeast 
Asia, many strains are fluoroquinolone resistant, and in Thailand, almost all 
strains are penicillin and tetracycline resistant (168).  Resistance and reduced 
susceptibility to penicillin are common in both Europe and the U.S., and this 
phenomenon has led to a change in the recommended treatment (100).  As the 
number of HIV infected persons has increased, tuberculosis has re-emerged as a 
serious problem, and multi-drug resistance in Mycobacterium tuberculosis is on 
the rise.  Even Yersinia pestis, the causative agent of plague, is acquiring 
antibiotic resistance.  An isolate in Madagascar, obtained from an infected boy, 
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was found to contain a plasmid with resistance to ampicillin, chloramphenicol, 
kanamycin, streptomycin, sulfonamide, and tetracycline (168).  Although many 
scientists who were working in the beginning of the antibiotic era were 
unconcerned and almost cavalier about microbial resistance to antibiotics, no one 
can deny that resistance is a major public health threat worldwide. 
 
Mechanisms of antibiotic action and resistance 
There are several major classes of antibiotics that can be categorized based 
on their mode of antibacterial action.  In general, antibiotics can be defined as 
those that inhibit cell wall synthesis, those that inhibit protein synthesis, and those 
that inhibit nucleic acid synthesis.  See table 1 for a summary of the major 
antibiotic classes.  The selective toxicity of antibiotics lies in the differences in 
cellular structures between eukaryotic and prokaryotic cells.  However, 
differences in cellular structure among bacterial species can lead to resistance to 
certain antibiotics.   
The definition of bacteria as resistant or susceptible is critical for 
clinicians.  It is also very important to note the difference between intrinsic and 
acquired resistance to an antibiotic.  Intrinsic resistance can best be described as 
resistance of an entire species to an antibiotic, based on inherent (and inherited) 
characteristics requiring no genetic alteration.  This is usually due to the absence 
of a target for the action of a given antibiotic or the inability of a specific drug to 
reach its target.  For example, mycoplasmas are always resistant to N-lactam 
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antibiotics since they lack peptidoglycan (which the N-lactams act upon).  
Similarly, the outer membrane of gram negative cells can prevent an antibiotic 
from reaching its target.  For example, Pseudomonas aeruginosa exhibits high 
intrinsic resistance to many antibiotics due to its drug efflux pumps and restricted 
outer membrane permeability. 
Acquired resistance can arise either through mutation or horizontal gene 
transfer.  Presence of the antibiotic in question leads to selection for resistant 
organisms, thereby shifting the population towards resistance.  The major 
mechanisms of acquired resistance are the ability of the microorganisms to 
destroy or modify the drug, alter the drug target, reduce uptake or increase efflux 
of the drug, and replace the metabolic step targeted by the drug.   
 
Inhibitors of Cell Wall Synthesis: 
There are two major groups of cell wall synthesis inhibitors, the N-lactams and the 
glycopeptides.  As bacterial cell walls are wholly unlike the membranes of 
eukaryotes, they are an obvious target for selectively toxic antibiotics.  The 
N-lactams include the penicillins, cephalosporins, and the carbapenems.  These 
agents bind to the penicillin binding proteins (PBP's) that cross-link strands of 
peptidoglycan in the cell wall.  In gram negative cells, this leads to the formation 
of fragile spheroplasts that are easily ruptured.  In gram positive cells, autolysis is 
triggered by the release of lipoteichoic acid (100).
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The mechanism of N-lactam resistance is via the action of the 
N-lactamases.  These enzymes catalyze hydrolysis of the N-lactam ring and, 
thereby, inactivate these antibiotics.  Many bacteria contain chromosomally 
encoded N-lactamases necessary for cell wall production and it is only through 
over-production of these enzymes that resistance occurs (100).  N-lactamases 
encoded on plasmids or other transmissible elements can lead to such over-
production and, therefore, to resistance (197).  There are also some bacteria that 
possess altered PBP's that result in reduced penicillin binding (100).   
Since the discovery of penicillin and resistant bacteria, various new 
versions of the N-lactams have been used that have different spectrums of activity 
and different susceptibility to N-lactamases.  Since the 1970s, several compounds, 
such as clavulanic acid, have been discovered that have the ability to bind  
irreversibly to N-lactamases and, thereby, inhibit their action.  Combinations of 
these compounds with N-lactam drugs have been very successful in treatment of 
disease (42). 
 
The glycopeptides are a group of antibiotics that include vancomycin, 
avoparcin, and others that bind to acyl-D-alanyl-D-alanine.  Binding of this 
compound prevents the addition of new subunits to the growing peptidoglycan 
cell wall.  These drugs are large molecules that are excluded from gram negative 
cells by the outer membrane, thus limiting their action to gram positive 
organisms.   
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Glycopeptide resistance was long thought to be rare, but has recently been 
shown to be quite common (42).  Resistance in enterococci has developed through 
newly discovered enzymes that use D-alanyl-D-lactate in place of acyl-D-alanyl-D-
alanine, allowing cell wall synthesis to continue.  Other mechanisms of resistance 
involve the over-production of peptidoglycan precursors which overwhelm the 
drug (100). 
 
Inhibitors of protein synthesis: 
There are many types of antibiotics that inhibit bacterial protein synthesis.  
These drugs take advantage of structural differences between bacterial ribosomes 
and eukaryotic ribosomes 
 
The aminoglycoside antibiotics are a group whose mechanism of action is 
not completely understood.  The three major groups of aminoglycosides are the 
streptomycins, neomycins, and kanamycins.  These drugs enter bacterial cells by 
an active transport that involves quinones that are absent in anaerobes and 
streptococci, thus excluding these organisms from the spectrum of action.  
Streptomycins act by binding to the 30S ribosomal subunit.  Kanamycins and 
neomycins bind to both the 50S subunit and to a site on the 30S subunit different 
from that of streptomycin (100).  Activity involving initiation complexes and cell 
membrane proteins that contribute to cell death plays a role in the action of these 
antibiotics, but this is poorly understood (42, 100). 
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There are three mechanisms of aminoglycoside resistance that have been 
identified to date.  The first involves only streptomycin.  Since streptomycin binds 
to one particular protein on the ribosome, alteration of this protein, even by a 
single amino acid in its structure, confers high-level resistance to the drug (42).  
The other mechanisms involve decreased uptake of the antibiotic and in one of 
these the cell membrane is altered, preventing active transport of the drug.  In the 
other, one of many enzymes alters the antibiotic as it enters the cell, causing a 
block in further active transport (42).   
 
Chloramphenicol is a broad-spectrum antibiotic that, although naturally 
occurring, is produced by chemical synthesis.  Chloramphenicol inhibits peptide 
bond formation on 70S ribosomes (42).  This drug is especially useful in that it 
can penetrate eukaryotic cells and cerebrospinal fluid, making it a drug of choice 
for treatment of meningitis and intracellular bacterial infections such as those 
caused by chlamydia.  It is not in widespread use, however, because of potentially 
fatal side-effects, namely, aplastic anemia (100).   
Resistance to chloramphenicol is conferred by the enzyme 
chloramphenicol acetyl-transferase.  A number of these enzymes have been 
discovered, each altering the chloramphenicol molecule to prevent binding to the 
bacterial ribosome.  Chloramphenicol resistance in gram negative cells can also 
arise from alteration in outer membrane permeability that prevents the drug from 
entering the cell (42). 
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The tetracyclines are another group of broad-spectrum antibiotics that 
inhibit bacterial protein synthesis.  They are brought into the cell by active 
transport and, once there, bind to the 30S subunit to prevent binding of aminoacyl 
tRNA (223).   
Resistance to the tetracyclines occurs via three mechanisms.  First, 
production of a membrane efflux pump removes the drug as rapidly as it enters 
and there are several genes encoding these pumps.  Second, several ribosome 
protection proteins act to prevent tetracycline from binding to the ribosome, thus 
conferring resistance.  Third, a protein found only in Bacteroides spp., 
enzymatically inactivates tetracycline (223).  Interestingly, efflux pump inhibitors 
have recently been discovered that may allow combinations of these inhibitors 
and tetracyclines to be used against previously resistant strains (55).   
 
The macrolides are a group of antibiotics commonly used to treat gram 
positive and intracellular bacterial pathogens.  Erythromycin was the first of 
these, and several other important macrolides have been discovered since, 
including clarithromycin and azithromycin.  Azithromycin has a longer plasma 
half-life which allows treatment with a single dose for some pathogens or a once 
daily dose for others.  Clarithromycin has enhanced absorption and causes less 
gastrointestinal discomfort (92).  It was originally believed that erythromycin 
inhibited protein synthesis by competing with amino acids for ribosomal binding 
sites, but newer research shows several mechanisms are involved (91).  The 
macrolides are now believed to promote dissociation of tRNA from the ribosome, 
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inhibit peptide bond formation, inhibit ribosome assembly, and prevent amino 
acid chain elongation (92).   
There are two major mechanisms of macrolide resistance.  First, an efflux 
pump has been found that removes the drug from the cell.  Second, modification 
of the ribosome can confer resistance.  Mutations at several sites of the ribosome 
can allosterically prevent macrolide binding and a common alteration is 
dimethylation of  one nucleotide on the 23S rRNA.  This dimethylation not only 
prevents macrolide binding, but also confers resistance to lincosamide and 
streptogramin antibiotics (92). 
 
The streptogramins are another class of antibiotic that inhibits bacterial 
protein synthesis, mostly in gram positive organisms (due to decreased 
permeability of the gram negative outer membrane).  These antibiotics are 
actually combinations of structurally different drugs, types A and B, that act 
synergistically.  These compounds bind to separate sites on the 50S subunit.  Type 
A drugs block attachment of substrates at two sites on the 50S subunit, whereas 
type B drugs cause release of incomplete protein chains.  The synergistic effect 
arises from a conformational change induced by the binding of a type A drug 
which significantly increases affinity of type B drugs (133).  Streptogramins 
currently in use include virginiamycin, pristinamycin, and 
quinupristin/dalfopristin. 
Resistance to streptogramin antibiotics can be found in several forms.  
Efflux pumps for both type A and B streptogramins have been identified.  Type A 
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streptogramins can be inactivated by one of the virginiamycin acetyl-transferases, 
and several enzymes have been identified that can inactivate type B 
streptogramins.  Alteration of bacterial ribosomal proteins or RNA can also confer 
resistance.  A common mutation is the dimethylation of one nucleotide on the 23S 
rRNA, mentioned previously, that gives rise to resistance to type B drugs, as well 
as macrolides and lincosamides (133). 
 
Inhibitors of nucleic acid synthesis:   
The sulfonamides and the diaminopyrimidines should be discussed 
together, in that both only indirectly inhibit nucleic acid synthesis by inhibiting 
folate synthesis.  Folate is a coenzyme necessary for the synthesis of purines and 
pyrimidines.  Although both types of drugs are useful on their own, they exhibit a 
synergistic effect when combined.  Sulfonamides are currently not used 
commonly in medicine, but the combination drug trimethoprim-sulfamethoxazole 
is sometimes used in the treatment of urinary tract infections.  Sulfonamides serve 
as an analog of p-aminobenzoic acid.  Therefore, they competitively inhibit an 
early step in folate synthesis.  Diaminopyrimidines, of which trimethoprim is the 
most common, inhibit dihydrofolate reductase, the enzyme that catalyzes the final 
step in folate synthesis (100).   
There are several resistance mechanisms microorganisms employ against 
each of the anti-folate drugs.  For example, sulfonamides are rendered ineffective 
by over-production of p-aminobenzoic acid or production of an altered 
dihydropteroate synthetase.  The substrate for dihydropteroate synthetase is 
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p-aminobenzoic acid, and the altered form has a much lower affinity for 
sulfonamides than for p-aminobenzoic acid (253).  Trimethoprim resistance can 
also result from several mechanisms, e.g., over-production of dihydrofolate 
reductase or production of an altered, drug-resistant form can lead to resistance 
(42).  In addition, both drugs can be enzymatically inactivated, resulting in 
resistance (253).   
 
The quinolones are a chemically varied class of broad-spectrum antibiotics 
widely used to treat many diseases, including gonorrhea and anthrax.  Drugs in 
this class include nalidixic acid, norfloxacin, and ciprofloxacin.  These drugs are 
commonly used and, worldwide, more ciprofloxacin is consumed than any other 
antibacterial agent (6).  Quinolones inhibit bacterial growth by acting on DNA 
gyrase and topoisomerase IV, which are necessary for correct functioning of 
supercoiled DNA (100).  Although quinolones target both enzymes, in gram 
negative organisms the primary target is DNA gyrase and, in gram positive 
organisms, the primary target is topoisomerase IV (228). 
There are three main mechanisms of resistance to quinolones.  Resistance 
to some quinolones occurs with decreased expression of membrane porins.  
Cross-resistance to other drugs requiring these porins for activity also results from 
these changes.  A second mechanism of resistance is expression of efflux pumps 
in both gram negative and gram positive organisms (197) and the third is 
alteration of the target enzymes.  Several mutations have been described in both 
quinolone target proteins that result in reduced binding affinities (228).  It is 
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believed that high-level quinolone resistance is brought about by a series of 
successive mutations in the target genes, rather than a single mutation (197). 
 
Sources of Resistance in the Environment 
Concern over resistance was originally confined to acquisition of 
resistance by microorganisms which cause epidemic disease and was an issue 
only with respect to clinically isolated strains.  However, in recent years, 
antibiotic resistant bacteria have been isolated from virtually every environment 
on earth.  This came as a surprise to many clinicians, because resistance was 
found in regions never exposed to human impacts.  Even as awareness of 
environmental resistance has increased, many investigators have continued to 
restrict their concern to only those pathogens that survive in the environment.  It 
was believed that they posed a danger to humans only if the disease they caused 
involved resistance to antibiotics. For many years, the focus of research on 
resistance in the environment reflected this viewpoint.  However, we now know 
that resistance genes can be spread far wider than once believed and a pool of 
resistance is developing in non-pathogenic organisms found in humans, animals, 
and the environment.  These non-pathogenic organisms serve as a source from 
which pathogens can acquire genes conferring resistance, and in turn, they can 
become resistant by acquiring genes from pathogens discharged into the 
environment, e.g. via sewage or agricultural runoff.  Thus, dissemination of 
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resistant bacteria is not only a problem of the resistant pathogens themselves, but 
also availability of resistance genes to pathogens via gene transfer.   
 
Although resistant organisms can be found naturally in the environment, 
most resistance is associated with man-made impacts of some type, either 
agricultural or direct human impact.  Antibiotic use in humans can lead to 
resistance in the environment via discharge of domestic sewage, hospital 
wastewater, and/or industrial pollution.  In addition to use in humans, antibiotics 
are added to animal feed to treat infections, as prophylactics, and in sub-
therapeutic doses as growth promoters.  Although no definitive numbers are 
available, some authors have published estimates and, by 1980, almost half of the 
antimicrobial agents used in the United States were used in animal feed (75).  In 
Denmark in 1994, a total of only 24 kg of vancomycin was used to treat infections 
in humans versus 24,000 kg for animals (275).  According to Levy (151), in 1998 
in the U.S., half of the 50 million pounds of antibiotics produced were used for 
agricultural applications.  There are a variety of positive effects from using 
antibiotics in animal feed, namely, inhibition of harmful gut flora which leads to 
increased growth rates and decreased mortality.  This has allowed more 
concentrated farming and an estimated $3.5 billion savings in production costs per 
year in the United States alone (75).  However, the practice has resulted in 
selection of antibiotic resistant organisms in the guts of food animals.  From there, 
these organisms enter the human food chain via contamination during 
slaughtering, or the environment via waste discharge.  Resistance has been found 
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to follow closely the use of any given antibiotic (1).  Although some investigators 
dispute any danger being posed by selection of resistant flora within the guts of 
animals, there is no doubt that such antibiotic use leads to higher concentrations 
of resistant pathogens and non-pathogens, as well as resistance genes, throughout 
the farm environment and nearby environments affected via runoff from farms.  
As will be discussed later, once resistant organisms are spread into the 
environment, they pose a health risk if they colonize or spread resistance genes to 





The poultry industry has become one of the largest livestock industries 
throughout the world, with a 44% production increase in the U.S. between 1982 
and 1994 (273).  In 1991, 600 billion eggs and 40 million tons of poultry meat 
were produced globally (273).  The same year, the U.S. alone produced 68 billion 
eggs and 6.1 billion broiler chickens (243).   
Antibiotics are used heavily throughout the poultry production process.  
Although antibiotic use statistics are difficult to obtain for the poultry production 
industry, one early study reported that 80% of poultry raised in the U.S. have been 
fed antibiotics (75).  Though many classes of antibiotics are used, 
fluoroquinolones, avoparcin, and virginiamycin are of particular concern, since 
resistance to these drugs is associated with resistance the human therapeutic drugs 
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ciprofloxacin, vancomycin, and quinupristin/dalfopristin, respectively.  
Enrofloxacin has been frequently used in the first week of life of chickens to 
alleviate disease arising from contamination during vaccination and in the third 
and fourth week to prevent respiratory infections, primarily those caused by 
E. coli (123) and avoparcin has been used as a growth promoter (144).  Although 
some of these antibiotics are no longer employed for these applications, others 
remain in use, and the resulting resistant organisms have been discharged into the 
environment for many years.   
The use of antibiotics in poultry leads to resistant organisms within the 
chickens themselves and throughout the production environment.  Resistant 
strains of many organisms, including Staphylococcus, Streptococcus, Clostridium,
Pseudomonas, and Aeromonas, have been isolated from these sources (137).   
Many surveillance studies have been done to measure prevalence of resistance in 
organisms of concern.   
Resistant E. coli are frequently isolated from live chickens and strains with 
multiple resistance to tetracycline, streptomycin, sulfonamides, gentamicin, 
fluoroquinolones, and virtually all other antibiotics, have been isolated (27, 34).  
Even after discontinuing an antibiotic, resistance persists.  In the 1970s, an 
experimental group of  chickens was given oxytetracycline and compared to a 
control group.  In 12 weeks, 70% of the E. coli isolates in the experimental group 
were resistant to more than two antibiotics, including streptomycin and 
ampicillin (151). 
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Campylobacter spp. are also of particular concern since colonization rates 
in chickens have ranged from 50% to 100%.  A longitudinal study carried out in 
Denmark showed prevalence on two farms to be 56% and 91% (124).  In 1998, 
Hein et al. (108) reported a prevalence of 45%.  Fluoroquinolones are most often 
used to treat campylobacteriosis and resistance to quinolones in Campylobacter 
spp. has increased greatly in the last 20 years.  In Austria, 50% of Campylobacter 
isolates from poultry were resistant to ciprofloxacin (108).  In The Netherlands, a 
1997 study found quinolone resistance in 29% of campylobacters from live 
poultry (124).    
Salmonella spp. are another important pathogen found in live chickens and 
antibiotic resistance in these species is on the rise.  In 1996, in Spain, 62% of 
isolates were resistant to at least one antibiotic and, in 2000, 82% were resistant 
(260).  In Denmark, in 1999, quinolone resistance was approximately 
26.5% (276). 
One of the most recent threats is resistance in Enterococcus spp. isolated 
from poultry.  Avoparcin has been used extensively throughout the world by 
poultry farmers and we now know that resistance to avoparcin also confers 
resistance to vancomycin.  Large numbers of VRE have been found in poultry, 
leading to the banning of avoparcin in animal production by several countries.  In 
a study conducted from 1995 to 1997, VRE were found in 30% of broiler 
carcasses (144).  After the ban of avoparcin, resistance decreased.  For example, 
in Denmark, a decline in VRE in chickens occurred from 80% to 5% (24).  A new 
drug, quinupristin/dalfopristin, has come into use against human VRE infections.  
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Although quinupristin/dalfopristin has never been approved for poultry use, 
isolates resistant to it have been obtained from broiler carcasses.  
Quinupristin/dalfopristin is an analog of virginiamycin which has been in 
agricultural use as a growth promoter for many years.  In a 2000 German study of 
turkey manure and broiler chicken carcasses, all of the manure isolates and 46% 
of chicken carcasses were positive for quinupristin/dalfopristin resistance.  In 
addition, resistance to other antibiotics in carcass isolates were 100% for 
erythromycin, 90% for oxytetracycline, 50% for ciprofloxacin, 20% for 
chloramphenicol, 20% for streptomycin, 5% for vancomycin, and 5% for 
ampicillin (271).  In an American study of poultry, quinupristin/dalfopristin 
resistant Enterococcus faecium was isolated from 77% of litter and transport 
containers sampled and 51.2% of cloacal swabs (107).  In a Michigan study of 
turkeys, virginiamycin resistance in E. faecium was as high as 100% (270). 
With the increase in poultry production, management of poultry waste is a 
serious problem.  In 1990, 408 million kg of manure were produced by broiler 
chickens in Maryland alone (187).  The components of poultry waste have been 
well studied, showing nitrogen and phosphorus content to be higher than in most 
animal manures (243).  Heavy metals, such as arsenic, copper, iron, selenium, and 
zinc, are often added to poultry feed to improve weight gain and to prevent 
disease (186).  Since most of the metals are not absorbed, they pass through the 
bird and are excreted with the waste (186).  In one study, Morrison (189) found 
arsenic levels of 15-30 ppm in the litter of chickens treated with the arsenic drug 
roxarsone.  Concentrations of metals in litter can range greatly, between 11 mg/kg 
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of lead and 1000 mg/kg of iron, and are directly related to the metal content of the 
feed (186, 187, 243).  Kunkle et al. (146) has shown that levels of metals in 
poultry feed are concentrated by at least 2.75 to 3.25 times in the litter.   
In addition to heavy metals, poultry manure contains large numbers of 
microorganisms, including Salmonella spp., Streptococcus spp., Staphylococcus 
spp., E. coli, P. aeruginosa, A. hydrophila, C. jejuni, and others (137).  Viable 
plate counts from fresh manure have ranged from 108 to 1011 CFU/g dry waste 
(243).  Numbers are high even in litter stored for more than three months (196).  
Nodar et al. (196) reported that aerobic heterotrophic bacteria counts averaged 
1.1x106 cells/g dry waste and total viable microorganisms were 6.3x107 cells/g 
dry waste over the course of a 14 week study.  In another study, Kelly et al. (137) 
showed that, although storage for four months resulted in significant declines in 
bacterial populations, Yersinia, Aeromonas, Campylobacter, Pseudomonas, and 
fecal coliforms could still be isolated.  
Many of these isolates from poultry manure are antibiotic and heavy metal 
resistant.  As in live chickens, resistance to virtually all classes of antibiotics can 
be found, and resistance to those antibiotics used as growth promoters is common.  
In feces from broiler farms, studies have shown resistance to ampicillin, 
chloramphenicol, clindamycin, erythromycin, streptomycin, tetracycline, and 
virginiamycin, ranging from 2% to 94.8%.  Tetracycline and erythromycin were 
highest at 94.8% and 89.7% respectively (280) with large percentages of these 
organisms resistant to multiple antibiotics. 
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The most common method of utilization of poultry waste is land 
application as manure.  It has been estimated that greater than 90% of the poultry 
manure generated in the U.S. is applied to agricultural lands as fertilizer, mainly 
(187).  Runoff from manure application is increasingly being recognized as a 
serious environmental problem.  Concentrated animal feeding operations impair 
more miles of river than the pollutants of all other industry sources and municipal 
sewers combined (273).   
Microorganisms, heavy metals, and antibiotic residues can be found in 
runoff from poultry manure.  The type of soil, rainfall amount, and method of 
manure application have a large impact on the fate of bacteria in manure applied 
to land.  Runoff was found to contain large numbers of bacteria after rainfall 
events (109).  In studies of soil cores, E. coli 0157:H7 as well as other E. coli 
strains isolated from poultry litter were found to remain viable (culturable), 
moving through the soil column.  The organisms continued to leach from several 
types of soil during rainfall events for more than two months (85, 176).  Giddens 
and Barnett (94) reported that total coliforms were a good indicator of pollution 
from poultry litter.  They showed that higher application rates of litter led to 
higher coliform counts and that rainfall led to increased runoff.  They also showed 
that if runoff was directed over grassed waterways, coliform numbers were 
reduced, although levels still exceeded water quality standards.  Other studies 
have also shown that coliform water quality standards are often exceeded, 
regardless of management practices (29).   The organisms in runoff may be 




Pigs are grown in confinement much like poultry, and both pneumonia and 
diarrhea are common problems.  Most pigs are given antibiotics through their feed 
for growth promotion or disease prevention.  In such instances, tylosin, 
sulfonamides, and tetracyclines are the most commonly used antibiotics, but other 
drugs are also employed (174).  Most reports on antibiotic resistance in isolates 
from swine involve Enterococcus spp.  In 1998 and 1999 in Belgium, 82% of 
swine samples yielded E. faecium isolates resistant to tylosin and 97% resistant to 
oxytetracycline (44).  Quinupristin/dalfopristin resistant enterococcal isolates 
were found in all pig manure samples in a German study and enterococcal 
resistance to other drugs was 100% for erythromycin, 100% for tetracycline, 
28.6% for ciprofloxacin, 4% for vancomycin, and 61.9% for streptomycin (271).  
In American swine farms, multiply resistant E. coli are common, even on farms 
with low antibiotic use.  For example 17% of isolates from high antibiotic use 
farms and 5% of sows from low antibiotic use farms had single resistance to 
tetracycline.  At the same farms, multiple resistance was found in 81.7% and 
79.3% of isolates, respectively (166).   
Rising resistance in the 1990s led several European countries to ban 
several antibiotics as growth promoters.  Beginning in 1995, Denmark banned 
avoparcin (24), then in 1998, virginiamycin (4).  By 1999, Danish food producers 
voluntarily stopped use of all growth promoters (4).  Similar bans have gone into 
effect throughout the European Union (2), leading to several studies to gauge the 
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impact on antibiotic resistance.  The results showed that in Denmark, 80% of E. 
faecium isolates from pigs were resistant to erythromycin in 1995, peaking at 
93.1% in 1996, but decreasing to 46.7% in 2000.  A similar decrease was 
observed in virginiamycin resistance, i.e., from 60% in 1995 to 22.5% in 2000.  
Vancomycin resistance was 20% in 1995 and dropped to just 6% in 2000 (4).  A 
study of Swiss pig farms involved comparison of enterococcal isolates just before 
the 1999 ban of growth promoters to several months after the ban.  Erythromycin 
resistance went from 96% to 34%, tetracycline resistance from 79% to 45%, and 
streptomycin resistance from 18% to 3% (36).  However, vancomycin resistance 
increased from 2% to 3% (36).  The lack of decrease in vancomycin resistance is 
not surprising since vancomycin was banned earlier, in 1997.  Yet, it is interesting 
that resistance was still detectible even after two years without vancomycin usage.   
As with poultry manure, swine manure is disposed of by application to 
farmland, a method that places large numbers of organisms, which may be 
antibiotic resistant, into the environment.  This was illustrated by  Sengelov et al. 
(240) in 2003, in a study to monitor the effects of application of pig manure to 
farmland.  The authors found the starting concentration of tetracycline resistant 
bacteria in the manure was 8.75 x 107 cells per milliliter and, after initial manure 
application, the levels of tetracycline resistant bacteria decreased until they 
matched the levels in control plots, five months later.  The authors also measured 
streptomycin and erythromycin resistance.  Even though neither drug had been 
used on any of the farms, the manure contained 1.6 x 106 erythromycin resistant 
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bacterial cells per milliliter and  between 2.3 x 107 and 4.6 x 107 streptomycin 
resistant bacterial cells per milliliter (240).   
 
Cattle Production: 
Antibiotics are used in cattle production in much the same way as in 
poultry and swine production.  The chief difference is in the concentration of 
waste from a pasture versus a chicken house but the same issues with resistance 
arise.  Cattle production includes beef, veal, and dairy cows with beef cows 
generally shipped to feedlots and kept in large groups.  Antibiotics are 
administered individually or to groups of animals via food and water to achieve 
growth promotion or to prevent diseases, i.e., pneumonia and diarrhea (174).  In 
1999, 83% of feedlots dispensed at least one antibiotic in food or water;  these 
included virginiamycin, tetracycline, tylosin, and neomycin (174).  In 1999, 90% 
of veal calves and 60% of beef cows were estimated to have been fed antibiotics 
(174).  Dairy calves are also housed in groups and are often administered 
antibiotics, including penicillin, cephalosporin, erythromycin, and tetracycline.  
Although these antibiotics are not usually administered in feed, most cows are 
routinely treated with antibiotics applied to the udder to prevent mastitis (101, 
174).   
As in poultry, many species of resistant bacteria can be isolated from 
cattle and the pathogens of particular concern include E. coli, Salmonella,
Enterococcus, and Campylobacter spp.  In 1998 and 1999, Butaye et al. (44) 
reported on resistance of enterococci in ruminants, with twenty percent of 
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Enterococcus faecium isolates resistant to ampicillin and 80% to tetracycline.  
Resistance to avoparcin, virginiamycin, and streptomycin was low.  In a study of 
cattle in Ireland, Salmonellae were isolated from 7.6% of carcasses and 2% in 
both fecal and rumen samples and included S. dublin, S. typhimurium, and 
S. agona. All of the S. typhimurium isolates were resistant to chloramphenicol, 
streptomycin, and tetracycline; all of the S. agona isolates were resistant to 
nalidixic acid and streptomycin; and 15% of S. dublin isolates were resistant to 
streptomycin (173).  S. typhimurium DT104, a serious pathogen in humans, was 
one of the strains isolated from these samples.  All of the isolates were resistant to 
multiple drugs, but susceptible to quinolones (173).  S. dublin is increasingly a 
problem in the U.S.  In a study of California dairy farms, 10% of S. dublin isolates 
were resistant to chloramphenicol (206).  In cattle in Pennsylvania and New York, 
McDonough et al. (172) found almost all isolates of S. dublin to be resistant to 
ampicillin, chloramphenicol, tetracycline, and neomycin.   
Antibiotic resistant bacteria are also capable of spreading through the 
cattle farm environment, even without antibiotic use.  In a 1990 study, Marshall, 
Petrowski, and Levy (164) were able to show that cows and pigs not given 
antibiotics, but fed resistant E. coli, continued to shed resistant bacteria for four 
months.  In addition, the test bacteria were recovered from bedding material, 
mice, flies, and animal caretakers for more than 4 weeks.   
Dairy calves have been shown to be colonized with sensitive E. coli as 
long as they were kept with their dams, but become colonized with multiple drug-
resistant E. coli shortly after being moved to other pens.  Multiple drug-resistant 
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E. coli also colonize veal calves that have not been treated with antibiotics but 
housed with other animals that were treated (114).    
 
Aquaculture: 
Fish farming has become a large agricultural business worldwide.  In the 
United States, the major crops are salmon, shrimp, rainbow trout, catfish, and 
tilapia (174).  Both fresh and saltwater farms are common and, as with other 
agricultural endeavors, antibiotics are generously applied.  However, antibiotic 
growth promoters are not approved in both the U.S. (174) and Denmark (236).  
Ormetoprim-sulfadiazine and oxytetracycline are used to treat infections in the 
U.S. (174) and oxolinic acid, sulfadiazine-trimethoprim, amoxicillin, 
oxytetracycline, and florfenicol, in Denmark (174, 236).  Treatment of fish in 
aquaculture with antibiotics is accomplished by the administration of medicated 
feed.  This application has a direct effect on the aquatic environment since the 
food is added to the water and uneaten food settles to the sediment or is dispersed.  
Thus, antibiotics not metabolized by the fish move directly into the environment 
(138).  One investigator reports that 70% to 80% of antibiotics applied to fish 
farms end up in the environment (105). 
A major fish pathogen in aquaculture is the motile aeromonad, especially 
Aeromonas salmonicida (147).  In treating disease caused by these bacteria, it is 
difficult to determine the true effects of the addition of antibiotics to the 
aquaculture farm, since the aquatic environment is so complex.  However, some 
studies have attempted to measure these effects.  Yet, most studies are in 
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agreement that isolates from fish farms or the effluent of fish farms have higher 
levels of resistance, including multiple resistance, than isolates from other areas.  
DePaola et al. (71) found oxytetracycline resistance in 58% - 83% of aeromonads 
isolated from catfish farms.  Similarly, 69% of aeromonads isolated from several 
Danish farms were oxytetracycline resistant (235).  Another Danish study 
demonstrated 43% sulfadiazine-trimethoprim resistance in aeromonads and 20% 
resistance to oxolinic acid.  Among Flavobacterium isolates, resistance to 
oxolinic acid was 100%, and resistance to amoxicillin was 36% (236).  In Italy, 
sediments surrounding fish farms were found to have higher ampicillin, 
tetracycline, and streptomycin resistance (53), whereas reports from Scottish 
farms have indicated resistance among A. salmonicida to be between 50% and 
55% for oxytetracycline, and between 31% and 54% for oxolinic acid (247).   
A different type of fish farming has developed in southeast Asia.  In 
integrated fish farming, chickens or pigs are housed in cages over fish ponds.  
These animals defecate into the water, where the nutrients support plankton 
growth which provides food for the fish.  Generally, the fish are given no extra 
feed and no antibiotics.  The chickens or pigs, however, do receive antibiotics in 
their feed, either as growth promoters or for prophylaxis.  Acinetobacter isolates 
from the water and sediment of these farms have been shown to have increased 
levels of resistance (213).  Another study of Aeromonas and Enterococcus isolates 
from fish showed increased resistance among Enterococcus spp. but not among 
Aeromonas spp., leading the authors to suggest that Aeromonas are poor 




In addition to the effects of agricultural uses of antibiotics, humans can 
have significant impact on the occurrence of antibiotic resistance in the 
environment.  Antibiotic resistant organisms from the human gastrointestinal 
tract, as well as unabsorbed antibiotics, can enter the environment via sewage.  
Domestic wastewater, however, often has less effect than hospital wastewater, 
since, in the latter, heavy antibiotic concentrations increase the impact.   
Antibiotics consumed by humans can act to select for resistant organisms 
in the human gut.  Both the resistant microorganisms and antibiotic residues are 
excreted, entering the sewage system.  Although most people consider the 
environment to be generally safe from contamination with untreated sewage, 
breaches occur frequently where leakage or overflow into groundwater or natural 
waters occurs (106).  Raw domestic sewage contains high numbers of bacteria, 
often including antibiotic resistant bacteria.  One report showed that, in healthy 
people, 80.5% of fecal samples contained resistant organisms (220).  Although 
VRE in the U.S. is associated with hospitals, in Europe, VRE is widespread in the  
community.  See tables 2 and 3. 
In Czechoslovakia, a study comparing resistance in municipal wastewater 
to that of clinical isolates showed higher resistance rates in wastewater for 
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Table 2. Low-level Vancomycin Resistant Enterococci from Domestic 
Wastewater  (33, 121, 237) 





Table 3. High-level Vancomycin Resistant Enterococci from Hospital 
Wastewater  (106, 258) 




the same species.  Gentamicin resistance in E. coli was 13.9% and 30% for 
Klebsiella and Enterobacter strains, respectively (143).   
Although sewage treatment processes reduce the numbers of bacteria in 
wastewater, the effluent will still generally contain large numbers of both resistant 
and susceptible bacteria. Schwartz et al. (237) showed a decrease in VRE from 
16% in untreated wastewater to 12.5% at the outlet.  High numbers of resistant 
coliforms have also been found in treatment plant effluents (220) and  rivers that 
a strains were also resistant to erythromycin (100%) 
b strains were also resistant to erythromycin (26%) 
c strains were also resistant to ampicillin (62%) and ciprofloxacin (2.5%) 
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receiving effluent from treatment plants have higher numbers of resistant 
organisms.   Even as early as 1983, Bayne, Blankson and Thirkell (31) found a 
significant increase in resistance to tetracycline, erythromycin, streptomycin, 
ampicillin, and penicillin in enterococci, when comparing isolates downstream 
from a treatment plant to those upstream.  Coliforms isolated from sites 
downstream of a treatment plant in the Tama river in Japan showed significant 
increases in resistance to ampicillin and tetracycline (122).  In Spain, resistance in 
Aeromonas isolates increased from 50% upstream to 90% downstream of a 
treatment plant effluent, and resistance in enterobacteria increased from 30% to 
50% (96).  In Sweden in 2003, erythromycin resistant enterococci were isolated 
from 63% of receiving water samples and VRE were isolated from 3% (33).   
Due to heavy antibiotic use, hospital wastewater contains larger numbers 
of resistant organisms than domestic wastewater.  In Florida, vancomycin 
resistant E. faecium were isolated, without enrichment, from hospital wastewater 
(106). VRE were found in 35% of the hospital sewage samples in two Swedish 
studies (33, 121, 237).  Twenty-five percent of enterococci were vancomycin 
resistant in a German study of biofilms from hospital wastewater, and of these, 
many were multiply resistant (237).  Reinthaler et al. (220) showed significantly 
higher percentages of E. coli in the inlet water of a treatment plant receiving 
hospital waste than two other treatment plants.   A study of Acinetobacter showed 
that an increase in the prevalence of oxytetracycline resistance was correlated 
with hospital wastewater (102).   
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Industrial pollution can also influence the incidence of antibiotic 
resistance, with pharmaceutical plants yielding a particularly strong effect.  Until 
the 1970s, it was common for pharmaceutical plant waste to be disposed of in 
regular landfills, but drug residues leaching from these landfills were detected in 
nearby groundwater systems (105).  Guardabassi et al. (102) found high levels of 
multiply resistant Acinetobacter in pharmaceutical plant effluents.   Higher levels 
of antibiotic resistance have also been associated with heavy metals from 
industrial pollution.  McArthur and Tuckfield (167) were able to show that 
antibiotic resistance was correlated with the heavy metal content of sediments 
downstream of a nuclear reactor complex.   
Resistant organisms in the environment 
 
The preceding discussion leads to the conclusion that there are several 
sources for antibiotics and antibiotic resistant organisms in the environment, but 
where can they be found, and at what levels?  Antibiotic bacteria can be found in 
almost every place on earth.  And although levels are higher in areas impacted by 
agriculture and humans, there are, nevertheless, still resistant organisms in far 
reaches where human impacts are negligible.  This should not be surprising since 
antibiotics are natural microbial products.  Those bacteria that live in the 
environment are subjected to numerous antagonistic effects from plants, fungi, 
and bacteria that produce antimicrobial chemicals in an effort to compete and 
survive.  In addition, antibiotic resistance genes may not have always served the 
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same purpose as they do presently.  An alteration of membrane permeability for 
one purpose may also confer resistance.  Heavy metals may also be found in the 
environment due to natural processes.  If a particular metal resistance is linked to 
drug resistance on a plasmid, there is an obvious selective pressure, even in the 
absence of human impacts.    
 
Soil ecosystems: 
Soils can contain high numbers of antibiotic resistant bacteria.  These 
numbers are generally higher in regions affected by pollution or agriculture, but 
there are unaffected areas that contain high levels as well, perhaps from natural 
production of antibiotics by soil bacteria.  Tropical soils have been found to 
contain antibiotic resistant Rhizobium, even in the absence of pollution (272).  
Pseudomonas aeruginosa isolated from various soils in Spain were resistant to 
many antibiotics and had higher levels of resistance than isolates from nearby 
surface waters.  Four of the isolates were resistant to ampicillin, cephalothin, 
chloramphenicol, furadantin, kanamycin, nalidixic acid, streptomycin, 
tetracycline, fosfomycin, sulfadiazine, gentamicin, neomycin, lead, arsenic, 
cadmium, uranium, molybdenum, thallium, zinc, tungsten, and chromium (163).   
Increased resistance has been found in soils after application of manure.  
Jensen et al. (131) found higher levels of resistance in Pseudomonas and Bacillus 
isolates after the application of pig manure.  Although these organisms were not 
present in the manure, evidence of gene transfer was not observed, implying that 
antibiotics in the manure were applying selective pressure on autochthonous soil 
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bacteria.  In Norway, fields that were without antibiotic application for 10 years, 
nevertheless had high levels of resistant organisms.  Resistance in organic soil 
was 72% and resistance in sandy soil was 74%, including resistance to 
chloramphenicol, tetracycline, ampicillin, and streptomycin (41).   
 
Groundwater: 
Many people, especially in rural areas, rely on untreated groundwater for 
their water supplies.  Few studies have been done to determine the antibiotic 
resistance of isolates from groundwater.  Unfortunately, agricultural applications 
of manure can affect groundwater supplies.  Chee-Sanford et al. (52) were able to 
show that tetracycline resistant enterococci could be isolated from groundwater 
underneath swine farms.  Even in wells 250 meters downstream from the farms, 
resistant bacteria were found and the same resistance genes in bacteria from the 
farm were isolated from soil bacteria in the groundwater, suggesting transfer of 
the resistance genes.  In West Virginia, coliforms in groundwater were found to 
have high levels of resistance.  That is, 87% of the coliforms were resistant to at 
least one antibiotic and 60% were multiply resistant.  Thirty percent of these 
isolates were resistant to tetracycline and nitrofurantoin, an antibiotic that is not 
commonly used (175).  Bacteria isolated from deep aquifer sediments in 
Washington state also had high levels of resistance to penicillin, ampicillin, 
carbenicillin, streptomycin, and tetracycline.  The investigators suggested that 
most of the resistance was intrinsic, but ca. one-third of the isolates contained 
plasmids, suggesting plasmid-mediated antibiotic resistance (82).  Enterococcal 
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isolates from wells in Alabama, Florida, Maryland, and Oregon were also found 
to be resistant to streptomycin (2.2%) and kanamycin (26%) (221). 
 
Lotic and lentic ecosystems: 
Most rivers are impacted by humans to a great extent.  Therefore, 
antibiotic resistant bacteria in those rivers may derive from wastewater effluent as 
discussed above.  In samples collected from river sites downstream of cities 
throughout the U.S., antibiotic resistant organisms are common.  For example, 
resistance to ampicillin ranged from 12% in the Ohio river to 60% in the Colorado 
river.  Resistance to other drugs, such as cephalothin (25% to 98%) and 
amoxicillin/clavulanic acid (0% to 68%) was also detected (22).  Resistance is 
common in polluted European rivers as well.  High quinolone resistance in 
Aeromonas (59% to nalidixic acid, 2% to ciprofloxacin) was reported to occur in 
rivers in Spain and France (97).  In polluted rivers in Morocco, coagulase-
negative staphylococci resistant to combinations of ampicillin, chloramphenicol, 
tetracycline, and erythromycin were isolated, some with resistance to all of the 
above drugs (139).  Isolates of Vibrio cholerae (non-01) and Aeromonas from the 
river Gomati in India were found to have multiple antibiotic resistance.  Thirty-
nine percent of V. cholerae isolates were resistant to two drugs, while 47% of 
aeromonads were doubly-resistant (211).  In the Niger river delta, between 55% 
and 72% of isolates from standard plate count agar were resistant to ampicillin.  
Resistance was also found to chloramphenicol, tetracycline, and streptomycin and 
multiple resistance was common (202).  In Korea, 53.6% of coliform isolates 
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from the Sumjin river were resistant to at least one antibiotic, e.g., 21.3% to 
quinolones (207).  Even though most rivers are affected to some extent by 
pollution, resistant organisms have been found even in remote locations.  
Pseudomonas isolated from a remote upland stream by Magee and Quinn (160) 
were resistant to ampicillin (18%), chloramphenicol (11%), kanamycin (50%), 
erythromycin (72%), tetracycline (6%), and cotrimoxazole (23%).  Multiple 
resistance was common but tetracycline resistance was observed to occur only 
with resistance to four other drugs. 
Resistant bacteria can also be found in high numbers in lakes.  In a study 
of two Spanish lakes, 71% of isolates were resistant to at least one antibiotic 
including erythromycin (31.1%), tetracycline (17.8%), chloramphenicol (22.2%), 
and penicillin (68.9%) (14).  Lobova et al. (156) found resistance percentages in a 
large brackish lake in Russia that were two to three times higher at a heavily used 
resort area near the shore than in the center of the lake.  In contrast, a study in 
England showed higher resistance in remote tarns than in a lake receiving sewage 
effluent.  The authors attribute this result to differences in species 
composition (135). 
 
Marine and estuarine ecosystems: 
Numerous studies have shown antibiotic resistant bacteria in coastal and 
estuarine environments, especially the Chesapeake Bay.  Resistant Aeromonas is 
easily isolated, though McNicol et al. (177) found only singly resistant species 
that did not contain R plasmids.  Morgan et al. (188) isolated several gram 
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negative species that were resistant to combinations of ampicillin, 
chloramphenicol, kanamycin, sulfadiazine, streptomycin, and tetracycline.  
Although resistance is generally greater in areas with more human impact, isolates 
of resistant environmental bacteria are common.  V. cholerae (non-01) and 
Pseudomonas, Erwinia, and Bacillus spp. resistant to ampicillin, 
chloramphenicol, and streptomycin have been isolated (10, 89).   
Resistant Bacillus, Vibrio, and Aeromonas isolates have been isolated 
from samples collected in the New York Bight, a heavily polluted ocean area off 
of the New York and New Jersey coasts (256).  Coastal waters in Italy yielded 
resistant Vibrio and Aeromonas spp., and resistance to ampicillin, erythromycin, 
and ciprofloxacin was detected in isolates of enterococci in samples collected off 
the coast of Greece (20, 74).  In marine sediments from Norway, resistant 
Aeromonas spp., E. coli, and Vibrio spp. have been isolated (16).  In samples 
collected from the coasts of Spain, Egypt, Puerto Rico, Maryland, North Carolina, 
and in the Gulf of Mexico, sites receiving runoff from sewage treatment plants, 
had a higher percentage of resistant organisms than sites with less human impact 
(30, 68, 229, 244).  In the Apalachicola Bay of Florida, 82% of E. coli isolates 
were resistant to at least one  antibiotic (209).  Resistance has also been found to 
be higher at the marine air-water interface than in bulk water (111).  Ampicillin 
resistance has even been found in plasmid-carrying isolates isolated from sea ice 
and sediments in the Antarctic (142).   
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Thus, many studies have shown the presence of resistant organisms 
throughout the world.  That resistant organisms can be found in places receiving 
little human impact should not be surprising, since antibiotics are natural 
products.  However, the evidence suggests that human and agricultural activity 
have a greater impact on the levels of resistant organisms in all environments, 
from rivers to pastures and between. 
 
Spread of resistance 
Historically, researchers have assumed that the danger posed by resistant 
organisms in the environment would be minimal, since bacteria (especially 
pathogens) introduced to an environment were generally believed to survive only 
for a relatively short time.  In the last 20 years, however, work by many 
investigators (11, 45, 210, 226) has shown that many bacterial species can survive 
far longer than once thought, and that organisms such as Vibrio cholerae, long 
considered to have a reservoir only in humans, not only survive, but are actually 
autochthonous to aquatic environments (57, 58).  This drastically increases the 
probability that humans will come into contact with resistant pathogens from 
runoff or sewage.  Additionally, even resistant non-pathogens can have a large 
impact on human health, serving as a source of resistance genes to indigenous 




There is ample evidence to suggest that horizontal transfer has spread 
genes farther than was previously thought possible.  A bacterium can gain 
antimicrobial resistance in at least one of two ways, either via mutation or 
horizontal gene transfer.  Mutations in chromosomal genes leading to antibiotic 
resistance occur at different rates, depending on the organism and the mechanism 
of resistance.  Resistance due to the inactivation of a gene will occur at a higher 
rate than resistance arising from mutation of a protein to a specific binding site.   
Resistance due to chromosomal mutations can be a single-step mutation 
that immediately leads to a high level of resistance or multi-step mutations, which 
successively lead to higher minimum inhibitory drug concentrations being 
required to prevent growth.  N-lactam resistance is a particularly common result of 
single-step mutations.  Since many organisms already produce N-lactamase at a 
low-level, mutations that lead to over-production are frequent.  Newer, extended 
spectrum N-lactam drugs are chemical derivatives to which N-lactamases are 
unable to bind.  However, a change in a single base-pair can alter the affinity of a 
N-lactamase sufficiently to enable binding and inactivation of broad-spectrum 
drugs (66).   
An example of a single-step mutation that is more common in certain 
organisms occurs in Mycobacterium tuberculosis. Streptomycin resistance results 
from altered 16S ribosomal RNA or ribosomal protein S12 that results in 
reduction of the binding affinity of streptomycin.  There are multiple copies of 
these genes in E. coli and other fast growing bacteria, so that resistance arising 
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from a mutation in a single gene is rarely observed.  In M. tuberculosis, there is 
only one copy of each of these genes, increasing the chances for resistance arising 
from mutation (66).   
Multi-step mutations leading to resistance occur after a series of mutations 
to targets in the cell.  For example, fluoroquinolone resistance is often the result 
of mutations in four genes that lead to increased expression of efflux pumps.  
Mutations in a single gene have only a minor effect on resistance, however, as 
successive mutations occur, resistance builds to a high level (197).    
Once resistance has developed, the genes can spread widely through 
horizontal gene transfer.  Horizontal gene transfer can occur through one of three 
ways: transduction, transformation, and conjugation.  Transduction is the transfer 
of genetic material by incorporation of bacterial DNA by a bacteriophage during 
packaging, and the subsequent infection of another bacterium.  Transfer of 
resistance by transduction was first shown with penicillin resistance in 
staphylococci in 1958 (91).  Although phages generally have a restricted host 
range, they are common in many environments and may therefore play an 
important role in transfer of resistance genes. 
Transformation refers to the uptake and incorporation of naked DNA from 
the microenvironment.  Naked DNA is made available through secretion or after 
cell lysis.  Although DNA can easily be destroyed in the environment, it can also 
be stabilized by binding to particles (67).  In order to be transformed, a bacterium 
must be competent.  There are many bacterial species that are either naturally 
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competent or in which competency can be induced by environmental 
conditions (67). 
Conjugation refers to the transfer of genetic material through direct cell-
to-cell contact accomplished by a pilus.  Originally thought to be a highly specific 
interaction that could only occur between closely related bacterial species, we 
now know that conjugation occurs between diverse species and even between 
gram positive and gram negative bacteria (59).   
 
In the 1940s and early 1950s, mutation and subsequent selection of 
resistant organisms was not given serious attention.  New drugs were being 
developed, and the frequency of mutation to drug resistance was low.  As each 
drug came into use, resistance developed and other new drugs were sought to 
replace the old.  However, it was soon apparent that mutation alone could not 
explain the patterns of resistance that were developing.   
In Japan, after the second world war, outbreaks of dysentery caused by 
Shigella were treated by sulfonamides but, by 1952, these drugs were ineffective 
as 80% of isolates were resistant.  Tetracycline, streptomycin, and 
chloramphenicol were introduced and resistance to these drugs soon was detected.  
At first, the isolates were resistant to only a single antibiotic, but in 1956, a strain 
was isolated with resistance to sulfonamides, tetracycline, streptomycin, and 
chloramphenicol.  Soon, multiply resistant isolates became common (80).  Given 
the frequency of mutation, it was unlikely that these resistances could have 
developed in single strains during the time in which they appeared.  In addition, 
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both multiply resistant and susceptible isolates of the same strain could be isolated 
from a single patient.  Multiply resistant strains were found in patients that had 
previously excreted susceptible strains and that were treated with only one drug.  
These observations could only be explained by transfer of drug resistance from 
one strain to another.  In 1959 and 1960, Ochiai (201), Akiba (8), and later, 
Mitsuhashi (184), separately published experiments showing that resistance could 
be transferred between Shigella and E. coli, both in vitro and in vivo. These 
"Resistance Factors" were found to be similar to the F factor, in that transfer 
occurred through conjugation.  Watanabe et al. (267, 268), showed that resistance 
factors were episomal in nature and proposed the term "Resistance Transfer 
Factor".  In the decade that followed, it was through the work of Watanabe, Datta 
and others (15, 64, 65, 180, 181, 268) that we learned the nature of R factors.  
Datta, Anderson, and  Kontomichalou were also able to demonstrate transmissible 
resistance in several of the Enterobacteriaceae (15, 64, 65).  We now know that 
R factors are plasmids that carry antibiotic resistance genes. 
Plasmids are circular molecules of DNA that are separate from the 
chromosome.  They often carry genes that provide antibiotic resistance, the ability 
to use alternate substrates, produce toxins, or other genes that can offer a survival 
advantage.  Plasmids that carry the genes necessary for conjugation are called 
conjugative plasmids, while non-conjugative plasmids can only be spread during 
conjugation brought on by a conjugative plasmid.  In a study of a large collection 
of enteric bacteria isolated before the discovery and use of antibiotics, Hughes 
and Datta (119) found that, although there was little antibiotic resistance among 
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these strains, 24% contained plasmids, suggesting that, although plasmids are 
useful in spreading resistance, their presence does not necessarily mean an 
organism is resistant. 
Other mobile genetic elements include transposons and integrons.  
Transposons are sequences of DNA that are capable of transposing or moving 
from one region to another or between plasmids and chromosomes.  Transposons 
can contain one or more genes, including those necessary for translocation, and 
often contain either resistance genes or genes necessary for degradative enzymes 
(238).  These genes are flanked by insertion sequences that allow insertion of the 
DNA into the chromosome or plasmid. 
Integrons are mobile elements that consist of conserved sequences of 
DNA bordering "cassettes" of genes.  The conserved sequences contain the genes 
necessary for integration, promotion, and capture of cassettes.  Gene cassettes are 
promoter-less units that contain the genes for antibiotic resistance or for virulence 
factors (225).  Integrons are capable of carrying several gene cassettes and are 
associated with multiple antibiotic resistance and pathogenicity islands. 
 In recent years, through the study of genomics, we have come to learn 
that horizontal gene transfer occurs far more widely and often then we ever 
imagined.  As complete genomes have been sequenced, evidence is mounting that 
not only do bacteria share genes with one another, but transfer occurs between all 
three domains of life, the Archaea, Eubacteria, and Eukaryotes.  In 1998, 
Lawrence and Ochman (148) showed that 18% of the E. coli genome had been 
acquired through horizontal transfer.  It has been shown that archaeal genes 
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comprise 24% of the Thermatoga maritima genome.  This is particularly 
surprising since T. maritime is thought to be among the slowest evolving, and on 
the deepest branch, of the Eubacteria (192).  Eukaryotes apparently trade genes 
with bacteria as well.  In an investigation of Deinococcus radiodurans, Makarova 
et al. (161) found several eukaryotic genes including human, yeast, and fly genes, 
some of which have only ever been found in eukaryotes.  Mycobacterium 
tuberculosis has also been reported to contain eukaryotic genes (87).  
 
Transfer in the environment 
 
Soil environments: 
Although there is a great deal of direct evidence showing gene transfer in 
the laboratory, the evidence for transfer in various environments is ample, though 
indirect, involving the comparison of gene sequences from different species or the 
use of microcosms or plasmid analysis.  Many studies have reported the presence 
of plasmids in environmental isolates.  Though this is not proof of horizontal gene 
transfer, it is strongly suggestive that it can occur especially in the presence of 
selective pressure.  Using phylogenetic analysis in Brazilian soil isolates, Weiner, 
Egan, and Wellington (272) found evidence of transfer of the streptomycin 
resistance gene strA between streptomycete species.  In another study using 
streptomycetes in microcosms, transfer of plasmids containing streptomycin 
resistance genes was found (112).  Plasmids have been found in opportunistic 
pathogenic bacteria isolated from residential garden soil and dairy farm soil in 
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Florida (77).  Plasmids were also found in 20% and 15% of isolates from two 
agricultural fields with no history of antibiotic application (41).   In samples from 
soil and sewage sludge, Top et al. (257) found transfer of broad host range 
plasmids from E. coli to Alcaligenes eutrophus. In a study of soil samples taken 
from a pasture before and after the application of pig manure, Jensen et al. (131) 
found that resistance in soil bacteria temporarily increased after the application of 
manure.  Götz and Smalla (99) were able to show a 10-fold increase in plasmid 
transfer from E. coli to Pseudomonas putida in agricultural soil after the 
application of manure.   
Studies focusing on the dangers of releasing genetically modified bacteria 
into the environment have been performed to examine the transfer of genes in the 
rhizosphere.  Antibiotic resistance markers were used and demonstrate not only 
horizontal gene transfer in the rhizosphere, but also horizontal transfer of 
resistance genes.  Transfer has been found to occur between several species under 
various environmental conditions.  In the wheat rhizosphere, Pseudomonas has 
been shown to transfer plasmids to indigenous bacteria (263).  Disturbingly, fecal 
bacteria are able to transfer genes to natural soil bacteria, as in the case of transfer 
from E. coli to Rhizobium spp. (222).  A criticism of some of these studies has 
been that they were done using microcosms and non-indigenous organisms with 
non-indigenous plasmids.  However, in a study using Pseudomonas fluorescens 
applied to sugar beet seeds, Lilley and Bailey (153) were able to demonstrate that 
Pseudomonas was able to colonize leaf and root structures and also acquired 
plasmids from indigenous bacteria.  Smit, Wolters, and van Elsas (245) were 
62
similarly able to show transfer of indigenous plasmids in the wheat rhizosphere 
and Sullivan et al. (252) that seven years after Rhizobium loti was applied to a 
field that had no natural rhizobia, non-symbiotic rhizobia were isolated containing 
several gene sequences that could only have been acquired via horizontal transfer 
from the original strain.    
 
Aquatic environments: 
As with studies of other environments, the evidence for horizontal gene 
transfer in marine and aquatic environments is largely circumstantial, relying on 
microcosm studies, in vitro transfer between aquatic organisms, and the presence 
of plasmids.  Antibiotic resistant organisms have been isolated from seawater 
samples collected from both sewage affected sites and control sites off the 
Spanish and U.S. coasts.  Plasmids were found in many of these isolates and 
strains from polluted areas had both more plasmids and higher levels of resistance 
(30).  In another investigation, 34% of environmental Vibrio, Aeromonas, E. coli,
and Pseudomonas isolates from Chesapeake Bay and Bangladesh were found to 
contain plasmids (178).  Hermansson, Jones, and Kjelleberg (111) found a very 
high percentage of multiply resistant bacteria (91%) in the marine air-water 
interface.  Of the pigmented and non-pigmented bacteria isolated, 44% and 39% 
respectively, contained plasmids.  Falbo et al. (79) were able to show multiply 
resistant Vibrio cholerae isolates from a cholera outbreak in Albania and Italy 
contained integrons that were transmissible.  Other V. cholerae isolates were 
shown to have a transposon containing resistance to trimethoprim, 0/0129, 
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streptomycin, and spectinomycin (95).  Although the isolates were clinical in 
origin, V. cholerae is known to be autochthonous to the estuarine environment.  
Plasmids have also been found in bacteria isolated from sediments and seawater 
from Antarctica.  Forty-two percent of sediment isolates and 20% of water 
isolates carried plasmids, some of which were associated with antibiotic 
resistance (142). 
Several studies have shown gene transfer between marine organisms or 
between marine organisms and enteric bacteria in vitro. Adams et al. (7) used the 
fish pathogen Aeromonas salmonicida to transfer a plasmid encoding tetracycline 
resistance to E. coli. In offshore seawater and sediment samples, Sizemore and 
Colwell (244) found antibiotic resistant bacteria in most samples, including those 
collected 100 miles offshore and from depths of 8200 meters.  Isolates considered 
autochthonous to the marine environment were examined for plasmids and used 
in mating experiments.  Of the 16 isolates studied, 50% contained plasmids.  
Several of these were able to transfer plasmids to E. coli (244).   
Vibrio parahaemolyticus strains isolated from the Chesapeake Bay were 
also found to be antibiotic resistant and to contain plasmids.  Mating experiments 
showed that resistance plasmids could be transferred from E. coli to V. 
parahaemolyticus in vitro (103).  In presumptive Vibrio spp. isolated from an oil 
field and unpolluted controls sites in the Gulf of Mexico, Hada and Sizemore 
(104) found that 18% of control isolates and 27% of oil-field isolates contained 
plasmids. 
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Transformation and transduction are theorized to occur in the marine 
environment, but few studies have been done explicitly to demonstrate the 
phenomenon.  However, the presence of large numbers of virus make it likely that 
transduction is an important means of gene transfer in the environment.  In three 
studies of different marine environments, similar counts of viruses were found.  
Wommack et al. (277) obtained counts of 2.5 x 107 viruses ml-1, while Bergh 
et al. (32) found 2.5 x 108 viruses ml-1, and Børsheim et al. (39) found 1.8 x 107
viruses  ml-1. Using marine bacteriophages and marine bacterial isolates, Jiang 
and Paul (132) were able to show that transduction can occur in vitro.
Transfer of a tetracycline resistance plasmid from A. salmonicida to 
indigenous bacteria in marine sediment microcosms has also been demonstrated, 
even without selective pressure from the presence of tetracycline. When 
tetracycline was present, however, 86.8% of isolates had acquired the plasmid, 
while only 45.8% without tetracycline (232).  Using green fluorescent protein 
(GFP), conjugative transfer was demonstrated between P. putida and indigenous 
bacteria in both artificial seawater and seawater samples (62), even under 
nutrient-limiting conditions (63).  Some investigators have speculated that 
conjugal transfer can occur only under excess nutrient conditions, but this has 
been shown not to be the case.  In microcosms and on plates, P. fluorescens 
transferred plasmids to marine isolates, even when in the viable but non-
culturable (VBNC) state (50).  Additionally, in an artificial seawater microcosm, 
both E. coli and marine Vibrio sp. S14 were capable of conjugation with another 
Vibrio S14 strain after nutrient starvation (98).   
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Horizontal gene transfer of antibiotic resistance also occurs in freshwater 
environments.  In an investigation of staphylococcal isolates from polluted 
streams in Morocco, Kessie et al. (139) found that several of the isolates from 
different species contained a tetracycline resistance plasmid of the same size.  In 
addition, one strain of Staphylococcus hyicus contained all but one of the 
plasmids that were found in the other isolates (139).  In a Korean river, 12.6% of 
coliform isolates contained integrons (207) and in sediment collected from a river 
in Wales, 9.4% of isolates from unpolluted sampling sites and 15% of isolates 
from polluted sampling sites contained plasmids, 86% of which were large 
enough to be conjugal plasmids (43). 
As stated above, transduction provides a means of gene transfer in 
freshwater environments.  In environmental chambers suspended in a freshwater 
lake, transduction of streptomycin resistance occurred in P. aeruginosa strains 
(190).  Using the same chamber system and different plasmids and phages, 
transduction was also shown both in the presence and absence of natural bacterial 
communities (233).   
Although 14% of isolates from bulk freshwater and 16.2% of isolates from 
the air-water interface contain plasmids, higher percentages of multiply resistant 
bacteria have been found at the air-water interface in freshwater lakes.  
P. aeruginosa transferred plasmids to indigenous bacteria isolated from the air-
water interface when cultured in microcosms.  Jones, Baines, and Genther (134) 
were able to show 100 times more conjugation at the interface than in the bulk 
freshwater, even under conditions of nutrient starvation.  Freshwater isolates can 
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serve as recipients of conjugation with  P. aeruginosa, as demonstrated in 
laboratory experiments (93).  P. aeruginosa is also capable of conjugation when 
tested in environmental chambers suspended in lake water, although the number 
of transconjugants were less in the presence of indigenous bacterial populations 
(203).  Epilithic bacteria have also been shown to be capable of conjugative 
transfer when examined in in vitro mating experiments with P. putida (113). 
 
Animal environments: 
Horizontal gene transfer occurs throughout animal environments, 
including farms and in the farm animals themselves.  Animals in the wild and 
insects also contribute to the spread of antibiotic resistance genes.  Integrons have 
been isolated from samples collected throughout poultry farms and poultry 
processing plants, using total microbial DNA rather than culturable organisms 
(225).  In a study of enteric bacteria isolated from horses, cattle, poultry, and 
reptiles, Goldstein et al. (6) found Class 1 integrases in 46% of the isolates tested.  
E. coli carrying transferable trimethoprim and ampicillin resistance plasmids from 
chickens carried the plasmids, even in the absence of selective pressure (51). 
Several studies of gene transfer and antibiotic resistance in wild animals, 
both from areas heavily impacted by humans and in remote regions have been 
done.  In a moose and voles from Finland, low levels of resistance were found, 
but, one isolate from a moose was capable of transferring streptomycin resistance 
to E. coli by conjugation (205).  Souza et al. (249) examined E. coli from wild 
rodents, cats, reptiles, and marsupials from Mexico and Australia, showing 
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plasmids in isolates from most of the samples, although those nearest to urban 
areas had significantly higher numbers (249).   
In enterococcal isolates from pigs, both streptogramin resistance and 
vancomycin resistance were found to be transferable in vitro (2, 271).  Of 
evernimicin resistant Enterococcus faecium isolates from pigs and broilers, all 
were capable of transferring resistance to a susceptible strain of E. faecium (3).  In 
one study, three of four E. coli isolates from diseased chickens were capable of 
transferring streptomycin and streptomycin, tetracycline, sulfa resistance to other 
E. coli strains (278).  Gene transfer has also been shown to occur among bacteria 
isolated from pens of calves.  Calves carrying Salmonella typhimurium type 
DT193 with a multiple resistance plasmid were found also to have a large number 
of E. coli of different antigenic groups in the same plasmid.  When muzzled 
calves were fed donor and recipient strains, no transconjugants were isolated, but 
when the calves were allowed to lick objects in their environments, 
transconjugants appeared in their feces (154, 255).   
There is good evidence of transfer in the poultry gastrointestinal tract.  For 
example, rifampin resistant E. faecium fed to broiler chicks transferred resistance 
to indigenous flora at a higher rate than that observed in vitro (193).  In another 
study, E. coli isolated from diseased poultry demonstrated high levels of multiple 
resistance and integrons.  The integrons were found to be part of the transposon 
Tn21, a transposon widespread among the E. coli isolates, as well as in 
Salmonella strains isolated at the same time (27).   
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Annelids and arthropods also play a role in gene transfer and antibiotic 
resistance.  In soil columns, earthworm activity was found to increase gene 
transfer from P. fluorescens to indigenous soil bacteria from several genera 
including Agrobacterium, Acinetobacter, Pasteurella, and Xanthomonas (61).  
The contribution of invertebrates to gene transfer in the environment is not limited 
to earthworms.  The epiphytes Enterobacter cloacae and Erwinia herbicola have 
been shown to transfer plasmids in the guts of silkworms (266).  Erwinia 
herbicola is also capable of transferring plasmids to resident gut flora in 
silkworms (265).  Strains of Bacillus thuringiensis were able to transfer plasmids 
containing toxin production genes in the guts of two species of moth larvae (125).  
Strains of Enterobacter cloacae were also able to transfer an antibiotic resistance 
plasmid in the gut of gutworms (19). 
 
The animal-environment-human web of resistance 
Ultimately, it is the prospect of being unable to treat human disease with 
antibiotics that is most disturbing.  Clearly, the use of antibiotics leads to 
increased antibiotic resistance in humans, animals, and the environment.  
Resistance genes can spread via horizontal gene transfer in practically every 
environment.  This raises the question of whether antibiotic resistance in the 
environment leads to antibiotic resistance in humans.  There is sufficient evidence 
to support the hypothesis that resistant organisms and resistance genes spread 
from humans to animals and to the environment, and vice versa.  Much of the 
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evidence comes from the presence of similar gene sequences in bacteria isolated 
from humans and animals and from examination of antibiotic resistant pathogens 
isolated from diseased humans that were traced to animals. 
In a study of human isolates of Bacteroides and isolates of Prevotella 
(normally found in the rumen of livestock) from different areas, sequences of the 
tetracycline resistance gene tetQ were almost identical (21, 194).  In a CDC 
investigation of salmonellosis outbreaks from 1971 to 1983, researchers found 
that of 38 outbreaks, where the source could be identified, food animals were the 
source of 69% of the antibiotic resistant strains, and 46% of susceptible strains 
(116).  In 1984, an outbreak of resistant salmonellosis across four Midwestern 
states was traced to beef cattle from South Dakota that had been fed 
antimicrobials. The isolates were all resistant to ampicillin, carbenicillin, and 
tetracycline.  Interestingly, it is believed that the patients were asymptomatically 
infected and that disease was initiated after the consumption of antibiotics for 
other reasons allowed for selection of the resistant strains (115).  Salmonella 
isolates have also been examined for their serotype and plasmid content.  Within 
groups of serotypes, plasmids from both humans and animals were generally 
identical.  One serotype and plasmid combination was found in 26 infected 
persons and in cattle from 20 states.  The epidemiology of the cases suggests that 
they were derived from a food source (200).  Salmonella typhimurium DT014 is 
generally resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, 
and tetracycline.  In Denmark in 1998, an outbreak of DT104 occurred in which 
the isolates were also resistant to nalidixic acid and had reduced susceptibility to 
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fluoroquinolones.  This reduced susceptibility was caused by a single mutation in 
the gyrase gene.  After tracing the outbreak to a pig farm, investigators found the 
same mutation in Salmonella isolated from the pigs and were unable to find the 
mutation in other isolates (185).  A 1995 outbreak of DT104 in England and 
Wales occurred in which a major risk factor was determined to be contact with 
sick calves.  Ten percent of the cases occurred on farms in a region where most 
residents live in urban areas (264).  A 1980 outbreak of Salmonella heidelberg 
that was resistant to chloramphenicol, sulfamethoxazole, and tetracycline 
occurred in infants in a hospital nursery.  The mother of one of the infants also 
developed diarrhea from the same strain.  She apparently had worked on a farm 
where there were sick calves before coming to the hospital to deliver her baby 
(159).  CDC data have shown that, in the U.S., the resistance patterns of 
Salmonella are more closely related to antibiotics given to farm animals that to 
those given to humans (17). 
Spread of resistant pathogens, other than Salmonella, from animals to 
humans is common.  In Taiwan, a large proportion of E. coli hospital isolates 
were either resistant to or had reduced susceptibility to fluoroquinolones (171).  
Human fluoroquinolone use was not high enough to explain the findings, 
especially in children, for whom fluoroquinolones are not approved and where the 
percentage of reduced susceptibility was as high as the rest of the population.  
However, large quantities of fluoroquinolones are used in poultry production, and 
a high percentage of food chickens purchased in Taiwanese markets are positive 
for fluoroquinolone resistant E. coli (171).  In Spain, Garau et al. (90) obtained 
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similar results.  Quinolone resistance was high in E. coli from both adults and 
children, even those never before exposed to quinolones.  Yet, 90% of chicken 
and 45% of pig E. coli isolates were quinolone resistant (90).   
In The Netherlands, it is likely that quinolone resistance in Campylobacter 
developed between 1985 and 1987.  During this time, enrofloxacin was 
introduced for animal use and norfloxacin was introduced for human use.  
Enrofloxacin was used extensively in poultry and in pigs, whereas norfloxacin 
was used in humans, mostly to treat urinary tract infections (76).  Quinolone 
resistance in campylobacters isolated from poultry went from 0% in 1982, to 14% 
in 1989, and in humans from 0% to 11% during that time (76).  A study of 
Campylobacter jejuni in Minnesota showed that the proportion of quinolone 
resistant isolates increased from1.3% in 1992, to 10.2% in 1998.  Although some 
outbreaks could be contributed to foreign travel, most were attributed to increased 
resistance in poultry (246). 
Enterococcal resistance can also be spread from animals to humans.  In 
France, the prevalence of VRE is much higher in cattle-rearing areas than in other 
regions of France and Europe.  However, the authors qualified their conclusions 
by saying that they may have found higher numbers due to an enrichment step 
during isolation (86).  A Dutch study of broiler farmers, laying-hen farmers and 
slaughterers showed that VRE in the human samples was correlated to VRE in the 
chickens.  Also suggestive of transfer from chickens to farmers was the fact that 
amoxicillin resistant enterococci were isolated only from broiler chickens and 
broiler farmers, not the other samples.  The transposon encoding vancomycin 
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resistance was also similar between isolates from farmers and chickens (261).  In 
Norway, VRE were isolated from 97% of chicken houses exposed to avoparcin 
and only 18% of non-exposed chicken houses.  Similarly, VRE was found in 60% 
of farmers from exposed farms and none from non-exposed farms (144).  Using 
pulsed field gel electrophoresis to compare poultry and human VRE isolates in 
The Netherlands, van den Braak et al. (262) found that poultry and human isolates 
were not clonal, however, there were two major genotypes of the vancomycin 
resistance gene vanA. Forty-two percent of poultry isolates were of one type, 
58% were of the other type.  All of the human isolates had the second phenotype 
(262).  Vancomycin resistance in enterococci is generally conferred by the 
transposon Tn1546.  In Europe, VRE and Tn1546 are widespread in the 
community, animals, and environment.  In the U.S., VRE have only been found in 
hospital acquired infections.  Simjee et al. (242) isolated a gentamicin resistant 
VRE strain from a canine urinary tract infection that contained Tn1546 identical 
to Tn1546 until now found only in human isolates.  Also studying Tn1546 in 271 
VRE isolates, Jensen (130) was able to show that European VRE have a base pair 
variation in the vanX gene, with either a G or a T in position 8234.  All poultry 
isolates had the G type, while all except one of the swine isolates had the T type.  
Human isolates had both types with one or the other dominating in a particular 
region (130).  Vancomycin has been heavily used in U.S. hospitals, and less so in 
European hospitals, whereas avoparcin, which is cross-resistant with vancomycin, 
has been used heavily in European agriculture, and has never been approved in 
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the U.S.  This is likely the reason for high community carriage in Europe and high 
nosocomial infection rates in the U.S. 
Quinupristin/dalfopristin is a streptogramin antibiotic that was approved in 
the U.S. and Europe in 1999.  However, three resistant streptococcal strains had 
been isolated from patients in 1997 (145).  Quinupristin/dalfopristin is cross-
resistant with virginiamycin which has been in use as an animal growth promoter 
for 20 years.  Within less than two years of approval, enterococcal isolates 
resistant to quinupristin/dalfopristin have been found with high frequency in 
poultry environments, food, humans, and wastewater (107, 136, 170, 242, 271).  
In Germany during the 1980s, nourseothricin, a streptothricin antibiotic, was used 
in pigs.  Though streptothricin antibiotics were not used in humans, 
nourseothricin resistant E. coli could be isolated from pig farmers and people 
living in pig farming areas (120).   
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II.  Chesapeake Bay Research 
Antibiotic Resistance in Vibrio cholerae Isolated from the Chesapeake Bay 
The Chesapeake Bay and its watershed provides a unique site for study of 
the spread of resistance genes and resistant microorganisms.  The largest estuary 
in the U.S., the bay has a watershed of 167,000 km2 that includes both rural and 
urban areas (37).  Environmental parameters vary greatly from the mouth of the 
bay to the upper reaches and the Bay comprises a number of different ecosystems 
and habitats.  Many studies of the microbiota of the bay have been done and 
several document antibiotic resistance and plasmid content of various microbial 
genera isolated from the bay.  McNicol et al. (177, 178) found plasmids in 21% of 
Aeromonas hydrophila and 18% of Vibrio cholerae strains isolated from bay 
water and resistance to erythromycin, polymyxin, streptomycin, and  tetracycline 
was detected (177, 178).  Studies by Allen (9, 10), Guerry (103), and Morgan et 
al. (188), showed antibiotic and heavy metal resistance in bacteria isolated from 
Chesapeake Bay water, sediment and shellfish.  Morgan et al. (188) examined 
antibiotic resistant coliforms isolated from water and shellfish, finding larger 
numbers of resistant bacteria in samples collected from near Baltimore Harbor 
than from other, less populated areas of Chesapeake Bay.  Of the strains isolated, 
73.7% were resistant to both ampicillin and streptomycin, and 25.9% were 
resistant to both ampicillin and tetracycline (188).  Guerry (103) isolated multiply 
resistant gram-negative bacteria including V. parahaemolyticus from water and 
shellfish in the bay.  As in other studies, numbers of resistant organisms were 
much higher near Baltimore harbor.  Thirty-seven percent of isolates were capable 
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of transferring antibiotic resistance markers to E. coli (103). Allen (9, 10) found 
antibiotic resistant Pseudomonas, Aeromonas, Vibrio, Flavobacterium,
Staphylococcus, and enteric species in samples from water and sediment.  Of the 
resistant isolates, 96% were resistant to two or more antibiotics. 
Long thought to be found only in contaminated waters, Vibrio cholerae,
the etiological agent of cholera, is now recognized as autochthonous to marine 
and estuarine waters throughout the world, including regions not currently 
affected by cholera.  To observe natural antibiotic resistance patterns, 256 strains 
of V. cholerae isolated between 1998 and 2000 were examined for antibiotic 
resistance.  The Chesapeake Bay geographical area represents a region free from 
epidemic cholera for almost 90 years.  Despite the lack of epidemic cholera, V. 
cholerae can be detected in bay water by a variety of methods, especially during 
the summer months, because its natural habitat includes estuaries.  The antibiotic 
resistance patterns of the Chesapeake Bay strains provide a reference pattern and 
may also provide better understanding of the ecology of antibiotic resistance in an 
estuarine environment. 
As part of a larger study on the occurrence of V. cholerae in the 
Chesapeake Bay, 256 strains of V. cholerae isolated between 1998 and 2000 were 
examined for antibiotic resistance (89, 157).  Sampling was done from January 
1998 to February 2000 at coastal sites throughout the upper Chesapeake Bay (see 
figure 1) and samples were collected from surface water, about 1m from the 
surface.  A surface water fraction and two plankton fractions also were collected 
using sterile plastic containers at each of the shore sampling sites.  Samples were  
76
 
transported to the laboratory at ambient temperature and processed within 6h of  
collection.  Surface water temperature and salinity were measured at the sites and 
V. cholerae was isolated using alkaline peptone water enrichment (54).  
Presumptive V. cholerae isolates were confirmed by PCR, using V. cholerae-
specific primers (56) or dot blotted onto Luria-Bertrani agar, transferred to filter 
Figure 1.  Location of Bay Sampling Sites 
Sampling site locations are as follows: 
Site B = Baltimore Harbor 
Site F = Susquehanna Flats 
Site K = Kent Island 
Site H = Horn Point Laboratory 
Site S = Smitsonian Environmental Research Center 
Map courtesy of  the National Atlas of the United States, 
http://nationalatlas.gov
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paper, and hybridized with a 32P-labelled V. cholerae probe.  Positive colonies 
were identified by autoradiography.  V. cholerae 01 and Vibrio mimicus grown on 
the same petri dish and processed along with presumptive colonies, served as 
positive and negative controls, respectively.  The Kirby-Bauer standard antibiotic 
disk diffusion test was used to assess antibiotic resistance using NCCLS 
breakpoints for Enterobacteriaceae as tentative standards for resistance and 
susceptibility (150).   
Of the 15 strains that were resistant to ampicillin, 8 (53.3%) were also 
intermediately resistant to streptomycin.  See table 4.  Twenty (57%) of the strains 
intermediately resistant to ampicillin were also intermediately resistant to 
streptomycin.  Ciprofloxacin resistant and intermediately resistant strains were 
also resistant to ampicillin and intermediately resistant to streptomycin.  The 
V. cholerae isolates that were cultured were non-01 and non-0139, but 
V. cholerae 01 strains were detected by direct fluorescent antibody assay.   There 
were not enough strains isolated to determine seasonality or sample site 
differences.  In a similar study in 1979, Allen (9) investigated the prevalence of 
antibiotic resistant bacteria isolated from the Chesapeake Bay.  Some results are 
presented in table 5.  In addition, Allen found multiple resistance in 96% of 
resistant strains.  Although Allen did not identify all genera to the species level, 
the Vibrio isolates she found had much higher levels of resistance.  It should be 
noted that the two studies are not directly comparable since only V. cholerae were 
investigated here and Allen did not identify isolates to the species level.   
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Table 4.  Antibiotic Resistance of V. cholerae Isolated from Chesapeake Bay 
Number of 
Strains (percent) 
Resistant Intermediate Susceptible 
Ampicillin 15 (5.8) 35 (13.7) 206 (80.5) 
Chloramphenicol 0 0 256 (100.0) 
Ciprofloxacin 1 (0.39) 1 (0.39) 254 (99.2) 
Streptomycin 4 (1.6) 76 (29.7) 176 (68.7) 
Sulfamethoxazole/
trimethoprim 
0 0 256 (100.0) 
Tetracycline 0 0 256 (100.0) 




Ampicillin 74% 34% 22% 
Chloramphenicol 72% 53% 40% 
Streptomycin 77% 86% 62% 
Tetracycline 17% 34% 27% 
data from Allen (9) 
 
Evaluation of Media and Culture Conditions for Enumeration of 
Heterotrophic Bacteria from Rivers in Maryland 
The Delmarva Peninsula of the Chesapeake Bay, comprising Maryland's 
Eastern Shore, a portion of Virginia, and the state of Delaware is one of the 
nation’s most concentrated chicken producing areas.  Poultry production 
accounted for 70% of the agricultural income of Delaware in 1991, and 31% of 
Maryland’s agricultural income in 2000 (37, 243).  Maryland ranked eighth in 
number of broilers produced with 283 million chickens totaling $462 million in 
2000 (165).  Poultry manure from these farms is applied to 42% of the cropland 
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on the Eastern Shore, and unfortunately, most of the drainage from that cropland 
flows into the Chesapeake Bay (251).   
The poultry industry has been an economic boon to Maryland and other 
regions, but a vast amount of waste is produced by this industry and contributes to 
runoff into the Chesapeake Bay.  Eutrophication of Chesapeake Bay by both point 
and non-point sources of pollution has been well documented (37, 126, 162, 251).  
Nitrogen and phosphorus have been recognized as contributing to hypoxia and 
blooms of toxic dinoflagellates, leading to a decrease in submerged aquatic 
vegetation (37, 251) and significant attention has been given to nutrients in 
agricultural runoff.  Nutrient management regulations have been established to 
mitigate damage but little attention has been paid to other possible effects of 
runoff (63), since the management practices deal mainly with reducing nitrogen 
and phosphorus input.   
In an effort to understand the relationship between poultry farms and 
antibiotic resistance in the river system of the Eastern Shore and the watershed of 
the Chesapeake Bay, a preliminary study was carried out (88).  Enumeration and 
isolation of bacteria from the aquatic environment by heterotrophic plate count 
has long been practiced in environmental microbiology.  Total viable, aerobic, 
heterotrophic bacterial counts are useful in ecological studies as a baseline for 
study of other organisms, as well as a first step in characterizing the population 
dynamics and ecology of a particular niche.  Such counts also allow further study 
of the phylogenetic and physiological diversity of various aquatic environments. 
There are many specialized types of media available for such counts.  Most are 
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limited in nutrient concentration in order to simulate the oligotrophic conditions 
most often encountered in aquatic and marine systems.  Although there are many 
such media available, little work has been done to determine which yields the 
largest number of bacteria.  Plate Count Agar (PCA), Heterotrophic Plate Count 
Agar (HPC), and R2A Agar (R2A) were compared for successful recovery to 
culture.   
A randomized complete block study was used, with water samples 
collected in November 2002, and May 2003, from four sites each in the Patuxent 
(Site numbers 1-4) and Pocomoke (Site numbers 5-8) rivers in Maryland.  See 
figure 2.  These rivers receive runoff from both agricultural and urban sources and 
drain into the Chesapeake Bay.  The Patuxent river is located on the Western 
Shore of the Chesapeake Bay and receives runoff from urban sources, while the 
Pocomoke river is on Maryland's Eastern Shore and receives mostly agricultural 
runoff, including a significant amount of runoff from poultry farms.   
Samples were collected below the surface at the shoreline, using sterile 
bottles, and transported to the laboratory in an insulated cooler.  Surface water 
temperature and salinity were measured at the sites using a field thermometer and 
a refractometer.  In the laboratory, samples were serially diluted in sterile saline 
and spread plates, in duplicate, were prepared on appropriate media.  PCA, HPC, 
and R2A plates were incubated at either 30º C for 24 hours or at 15º C for 
6 days (88).   
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Figure 2.  Location of Riverine Sampling Sites. 
 
In November 2002, water temperatures ranged from 9º C to 12º C and in 
May 2003 from 16º C to 17º C.  At each site and within each temperature, R2A 
yielded significantly higher counts than either PCA or HPC (p<0.01).  As shown 
in figures 3 and 4, in November, plates incubated at 15º C yielded higher numbers 
of bacterial colonies than plates at 30º C.  However, in May, this pattern was 
reversed (figures 5 and 6).  In both months, within each incubation temperature, 
Sites 1-4 are located along the Patuxent river 
Sites 5-8 are along the Pocomoke river 
Map courtesy of  the National Atlas of the United States, 
http://nationalatlas.gov
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neither PCA nor HPC counts were significantly higher than the other.  Pocomoke 
river water samples generally yielded higher bacterial counts than water samples 
from the Patuxent.  Bacterial counts for water samples collected in November 
ranged from 1.6 x 102 to 2.89 x 103 cells/ml for Patuxent samples and from 2.7 x 
102 to 8.6 x 104 cells/ml for the Pocomoke.  Bacterial counts in May ranged from 
7.1 x 102 to 3.7 x 105 cells/ml for Patuxent water samples and from 6.3 x 103 to 
3.14 x 105 cells/ml in Pocomoke samples. 
There were no significant differences between the sites sampled.  
Temperature and salinity measurements were similar and the numbers of bacteria 
in water samples collected from each river were similar.  Higher bacterial 
numbers in samples from the Pocomoke river may be explained by higher nutrient 
concentration from the runoff from agricultural areas on Maryland’s Eastern 
Shore.  R2A agar consistently supported greater numbers of bacteria.   
Of the media available for obtaining total viable, aerobic, heterotrophic 
bacterial counts, results of the study by Gangle et al. (88) showed that, for the two 
rivers studied, the two seasons, and different incubation temperatures, R2A agar 
yielded higher bacterial recovery than either PCA or HPC and can be used to 
monitor antibiotic resistance patterns of bacteria in the estuarine environment.  
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Figure 3.  November 15E Incubation Heterotrophic Plate Counts 


















Data shown are means of two replicates 
 
Figure 4.  November 30E Incubation Heterotrophic Plate Counts 























Figure 5.  May 15E Incubation Heterotrophic Plate Counts 


















Data shown are means of two replicates 
 
Figure 6.  May 30E Incubation Heterotrophic Plate Counts 



















Data shown are means of two replicates 
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III.  Conclusion 
Since the discovery and introduction of antibiotics, microbial resistance to 
antibiotics has steadily increased.  Humans have significant influence on bacterial 
populations in the natural environment via large scale selective pressure through 
waste management, agricultural, and other practices, notably, in antibiotic 
resistance.  In past years, development of resistance to antibiotics was not 
considered a serious problem because of the notion that there would always be a 
new antibiotic discovered.  The reality is, whether for economic, political, or 
scientific reasons, no novel antibiotics have been produced for several years, and 
few are on the horizon.  While humans have been idle in this biological arms race, 
bacteria continue to develop resistance against each new drug we create.  
Infections once easily curable are now regarded as a growing threat from the 
drug-resistant microbial agents of these diseases. 
While the seriousness of the problem of antibiotic resistance is now 
recognized, the complex web of resistance linking humans, animals, and the 
environment is only beginning to be understood.  Indiscriminant use of antibiotics 
for medical purposes has taken the brunt of the blame, namely, use by those 
physicians who prescribe antibiotics for viral infections to make their patients feel 
comfortable when antibiotics are known to be useless against viruses.  In fact, all 
antibiotic use, whether medical, agricultural, and necessary or not, leads to 
increased resistance.   
Antimicrobial use in agriculture and aquaculture has been blamed for the 
increase in microbial resistance to antibiotics.  But can this use lead to detrimental 
86
effects in humans?  Some argue that no link has yet been proven (208, 216, 217).  
Ample evidence presented in this review suggests such a link.  Many studies have 
shown that application of antibiotics leads to resistance in the guts of animals, and 
that humans acquire resistant bacteria via contact with farm animals and the 
farming environment.  Because slaughter and processing of food animals 
contaminates the meat with fecal bacteria, humans can also acquire resistant 
organisms through the food chain.   
As illustrated in figure 7, agricultural antibiotic use leads to increased 
resistance in the environment since resistant organisms and antibiotic residues are 
excreted as waste that is frequently spread onto farmland as organic fertilizer.  
Fecal bacteria survive long periods in the environment and spread through runoff 
into groundwater, rivers, and marine ecosystems. 
Some investigators claim that there is danger to humans only if resistant 
pathogens spread to humans (46, 215-217).  However, horizontal gene transfer 
occurs in the guts of humans and animals and in a variety of ecosystems, creating 
a pool of resistance in fields and waters.  This leads to several dangers for 
humans.  Even if people do not directly contract resistant disease from food 
animals, there is the danger of contact with resistant fecal pathogens from the 
environment.  Additionally, pathogens that are autochthonous to the environment 
can acquire resistance genes from animal fecal bacteria.  Aquatic pathogens, such 
as Vibrio vulnificus would be very dangerous if they did not respond to antibiotic 
treatment.  There is another level of danger, however.  Non-pathogenic bacteria 
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can also acquire resistance genes and serve as a continuing source of resistance 
for other bacteria, both in the environment, and in the human gut.   
Figure 7. Animal-Environment-Human Web of Resistance Conceptual 
Diagram  
 
Symbols for diagrams courtesy of the Integration and Application Network 
(ian.umces.edu/symbols), University of Maryland Center for Environmental Science. 
 
As the effectiveness of antibiotics for medical applications declines, the 
dilemma of antimicrobial use in non-medical applications must be addressed from 
a public health perspective.  How then, do we approach this problem?  Several 
recommendations can be made.  Monitoring of antibiotic resistance is necessary 
to keep abreast of changes, especially any changes that may result from 
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management decisions.  In the U.S., there is only one governmental organization 
whose function is to monitor antibiotic resistance: the National Antimicrobial 
Resistance Monitoring System (NARMS).  NARMS is a joint venture of the 
Centers for Disease Control and Prevention (CDC), the Food and Drug 
Administration (FDA), and the U.S. Department of Agriculture (USDA) (47).  
NARMS receives isolates of food-borne pathogens from public health 
laboratories around the country to test for and monitor antibiotic resistance.  
Unfortunately, their purview is limited to several food-borne pathogens and 
indicator organisms isolated from food, food animals and humans.  In the 
European Union, there are resistance monitoring agencies much like NARMS in 
most countries.  However, the testing of these agencies is limited to veterinary 
pathogens, zoonotic agents, and indicator bacteria, and only from food animals, 
farms, and humans (279).  There are non-governmental organizations that attempt 
to monitor resistance, one of which is the Alliance for the Prudent Use of 
Antibiotics (APUA).  The APUA is an advocacy group comprised mostly of 
scientists whose function is to coordinate programs like the Global Advisory on 
Antibiotic Resistance Data program, which collects data on resistance from global 
sources, and the Reservoirs of Antibiotic Resistance Network, which provides 
funding for projects to study antibiotic resistance in non-pathogenic bacteria (12).  
The most common source of information on resistance in the environment is 
short-term studies by researchers.  Much of this data is compiled by groups like 
the APUA, but there is no program of on-going monitoring of environmental 
resistance in the U.S. or European Union.   
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There are options available to reduce the threat of antibiotic resistance.  
Since one of the ways that resistant organisms are spread into the environment is 
through land application of poultry manure, treating the manure may reduce or 
eliminate the threat.  Reducing the use of antibiotics through legal bans or 
alternative health methods may also be viable.  
Many scientists feel that a reduction in agricultural antibiotic use will only 
happen if there is a ban on that use.  Some have suggested banning all "human-
use" antibiotics and some have suggested banning only non-therapeutic use, 
including growth promotion.  Human-use antibiotics are those that are medically 
important to humans.  There are problems with banning medically important 
drugs.  First, there are only a few classes of antibiotics and most drugs that are not 
specifically used in humans are structurally related (and cross-resistant) to those 
that are.  Second, as in the case of virginiamycin and the streptogramins, a drug, 
or class of drugs, may not be medically important now, but may someday become 
important. 
Banning of growth promoters is the step most often recommended to deal 
with antibiotic resistance in the environment.  Most agricultural use of antibiotics 
(at least in the U.S.) is for growth promotion.  Estimates vary, but surveys suggest 
that between 15 million and 28 million pounds of antibiotics are used for non-
therapeutic uses in the U.S. each year (152, 174).  The efficacy of a growth 
promoter ban is unknown.  All European Union countries currently ban the use of 
growth promoters.  After the ban in the E.U., resistance has decreased (in some 
cases drastically) (217).  But, while it is important to reduce the levels of 
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resistance in our environment, this solution is not perfect.  With the overall 
decrease in antibiotic usage, therapeutic use has increased to deal with an increase 
in disease.  Some authors argue that animal disease has increased and the 
finishing weights of animals have decreased (46, 217).  And, in addition to 
finding only a limited decrease in resistance in humans, there has actually been an 
increase in food-borne disease (46).   
To reduce the effect of bacterial runoff from manure, Perdue Farms Inc. 
has joined with a company called AgriRecycle to produce a pelletized fertilizer 
called MicroStart60™ from poultry litter.  The plant, located in Delaware, was 
designed to process 95,000 tons of litter each year and the company will pick up 
litter from any farmer, regardless of company affiliation.  The process includes 
heating to kill any microorganisms and to completely dry the product (69).  
Perdue's goal is to remove nutrients from the Delmarva peninsula by shipping 
them to the rest of the country.  The process should work, however, the economic 
feasibility (and therefore long-term sustainability) is unknown. 
Long-term storage of manure before land application has also been 
suggested as a means to eliminate bacteria from poultry manure.  This can be a 
simple, low-cost method of treatment that has some utility, however, even after 
three to four months, there are reduced, but still significant numbers of multiply 
antibiotic resistant bacteria found in poultry manure (137, 196).   
Another method to reduce bacterial runoff that is useful is the use of 
buffer zones.  Using riparian or vegetated buffer zones can reduce sediment loss 
and runoff of bacteria.  Giddens and Barnett (94) were able to show drastically 
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reduced bacterial runoff over grassland versus fallow land.  Both buffer zones and 
manure storage are not effective in completely eliminating bacterial runoff, but 
they are useful in that they are already encouraged, at least in the Chesapeake Bay 
region, due to nutrient management regulations, and they do lead to some 
reduction in runoff (37). 
A reduction in the use of antibiotics is generally regarded as the most 
effective way to reduce antibiotic resistance, and there are several ways that 
animal producers can reduce their need.  If vaccines are developed for important 
diseases, the animals can be immunized and therefore the need for antibiotics is 
reduced.  Vaccines are under development for Salmonella and coccidiosis in 
poultry, and for many bacteria and viral diseases in pigs and cattle (174).  
Vaccination has been very successful in aquaculture.  In Norway, antibiotic use 
has decreased drastically since the development of vaccines against Aeromonas 
salmonicida and Vibrio salmonicida infections (248). 
Probiotics are beneficial bacteria, generally lactic acid bacteria, that are 
fed to animals (or humans) in an effort to promote greater health.  These bacteria 
can competitively exclude harmful bacteria by occupying a particular growth 
niche and/or producing antagonistic conditions for harmful bacteria.  Probiotics 
have been shown to have some success, but results are inconsistent (5).  In 
addition to probiotics, general steps can be taken to reduce disease in animal 
production.  Good herd management, including disease screening, good 
sanitation, and appropriate air and water quality can help to maintain healthy 
animals and reduce the need for antibiotics (174).  Other potential options include 
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using immune modulators, such as cytokines, to increase growth (158), or 
bacteriophages to treat bacterial infections (118).   
While some steps are being taken to reduce agricultural antibiotic use, 
more needs to be done.  The evidence that links agricultural use of antibiotics to 
antibiotic resistance in both the environment and humans is compelling, and 
because of the tremendous possibilities for horizontal gene transfer and the spread 
of resistant organisms, we must recognize and deal with the threat posed by 
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